abstracts

0

Page précédente

Abstracts Lille 2003

Type présentation Jour N° Session N°communication Auteurs Titre Adresses
Orale Lundi 14/04    1 O1 H Bourgoin (1); C Le Guellec (1); F Mentré (2); M Büchler (3); P Marquet (4); Y Lebranchu (3); E Autret-Leca (1); G Paintaud (1); BAYESIAN ESTIMATION OF CYCLOSPORINE AREA UNDER THE CURVE IN RENAL TRANSPLANT PATIENTS
Abstract complet
(1) Department of pharmacology, University hospital, TOURS; (2) Department of epidemiology and biostatistics, Bichat hospital, PARIS; (3) Department of nephrology and clinical immunology, University hospital, TOURS; (4) Department of pharmacology and toxicology, University hospital, LIMOGES;
Orale Lundi 14/04    1 O10 K Brendel (1); M Legrand (1); C Goujard (2); AM Taburet (3); B Diquet (4); F Mentré (1); ET Cophar1-Anrs102 study group (5); POPULATION PHARMACOKINETIC ANALYSIS OF INDINAVIR IN HIV CONTROLLED PATIENTS UNDER STABLE REGIMEN
Abstract complet
(1) DEBRC, Hôpital Bichat, PARIS; (2) Maladies Infectieuses, Hôpital Bicêtre, KREMLIN-BICÊTRE; (3) Pharmacie, Hôpital Bicêtre, KREMLIN-BICÊTRE; (4) Pharmacologie-Toxicologie, CHU Angers, ANGERS; (5) AC5, ANRS, PARIS;
Orale Lundi 14/04    1 O2 M Legrand (1); C Goujard (2); F Mentré (1); B Diquet (3); AM Taburet (4); ET Cophar1-Anrs102 study group (5); NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS PLASMA CONCENTRATIONS IN PATIENTS WITH SUSTAINED VIROLOGICAL RESPONSE ON HAART
Abstract complet
(1) DEBRC, Hôpital Bichat, PARIS; (2) Maladies Infectieuses, Hôpital Bicêtre, KREMLIN-BICÊTRE; (3) Pharmacologie-Toxicologie, CHU Angers, ANGERS; (4) Pharmacie, Hôpital Bicêtre, KREMLIN-BICÊTRE; (5) AC5, ANRS, PARIS;
Orale Lundi 14/04    1 O3 JM Tréluyer (1); JP Morini (2); J Dimet (1); I Gorin (2); E Rey (1); J Deleuze (2); PF Ceccaldi (1); JP Escande (2); G Pons (1); N Dupin (2); HIGH CONCENTRATIONS OF NELFINAVIR AS AN INDEPENDENT RISK FACTOR FOR LIPODYSTROPHY IN HIV-INFECTED PATIENTS
Abstract complet
(1) Pharmacologie, Hôpital Cochin Saint Vincent de Paul, PARIS; (2) Dermatologie, Hôpital Cochin Saint Vincent de Paul, PARIS;
Orale Lundi 14/04    1 O4 H Chappuy (1); JM Treluyer (1); J Dimet (1); G Firtion (2); E Rey (1); M Foucher (2); G Pons (1); L Mandelbrot (3); MATERNAL-FETAL TRANSFER AND AMNIOTIC FLUID ACCUMULATION FLUID ACCUMULATION OF ANTIRETROVIRAL DRUGS IN HIV INFECTED PREGNANT WOMEN
Abstract complet
(1) Pharmacologie, Hôpital Cochin Saint Vincent de Paul, PARIS; (2) Obstétrique, Hôpital Cochin Saint Vincent de Paul, PARIS; (3) Obstétrique, Hôpital Louis Mourier, COLOMBES;
Orale Lundi 14/04    1 O5 B Guillet (1); N Simon (2); J Sampol (1); Y Berland (1); B Dussol (1); P Brunet (1); POPULATION PHARMACOKINETICS OF ENOXAPARIN IN HAEMODIALYZED PATIENTS
Abstract complet
(1) Service de néphrologie, Hôpital de la conception, MARSEILLE; (2) Laboratoire de Pharmacologie médicale et clinique, Faculté de médecine, MARSEILLE;
Orale Lundi 14/04    1 O6 JS Hulot (1); C Vantelon (1); A Ankri (2); G Montalescot (3); PH Lechat (1); POPULATION PHARMACOKINETICS OF THE LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN IN ELDERLY OR PATIENTS WITH RENAL FAILURE ADMITTED IN CARDIOLOGY INTENSIVE CARE UNIT
Abstract complet
(1) Service de Pharmacologie, Hôpital Pitié-Salpétrière, PARIS; (2) Laboratoire d’hémostase, Hôpital Pitié-Salpétrière, PARIS; (3) Service de Cardiologie, Hôpital Pitié-Salpétrière, PARIS;
Orale Lundi 14/04    1 O7 A Prémaud (1); J Debord (1); A Rousseau (1); Y Le Meur (2); O Toupance (3); G Hoizey (4); P Marquet (1); EVOLUTION OF THE PHARMACOKINETICS OF MYCOPHENOLIC ACID WITH POST-TRANSPLANTATION DELAY IN RENAL TRANSPLANT RECIPIENTS
Abstract complet
(1) Pharmacologie et Toxicologie, CHU, LIMOGES; (2) Néphrologie, CHU, LIMOGES; (3) Néphrologie et Hémodialyse, CHU, REIMS; (4) Pharmacologie et Toxicologie, CHU, REIMS;
Orale Lundi 14/04    1 O8 F Saint-Marcoux (1); A Rousseau (1); Y Le Meur (2); O Toupance (3); G Hoizey (4); J Debord (1); P Marquet (1); EVOLUTION OF CYCLOSPORINE (CSA) PHARMACOKINETICS WITHIN THE FIRST MONTH AFTER RENAL TRANSPLANTATION : PRELIMINARY RESULTS OF A BI-CENTER CLINICAL STUDY
Abstract complet
(1) Pharmacologie et Toxicologie, CHU, LIMOGES; (2) Néphrologie, CHU, LIMOGES; (3) Néphrologie et Hémodialyse, CHU, REIMS; (4) Pharmacologie et Toxicologie, CHU, REIMS;
Orale Lundi 14/04    1 O9 A Liutkus (1); M Popon (1); C Loirat (2); P Cochat (3); E Jacqz-Aigrain (1); OPTIMIZING CYCLOSPORINE MONITORING IN PAEDIATRIC RENAL TRANSPLANTED PATIENTS
Abstract complet
(1) Pharmacologie Pédiatrique – Pharmacogénétique, Hôpital Robert Debré, PARIS; (2) Néphrologie Pédiatrique, Hôpital Robert Debré, PARIS; (3) Néphrologie Pédiatrique, Hôpital Edouard Herriot, LYON;
Orale Lundi 14/04    2 O11 MN Beyens (1); C Guy (1); M Ratrema (1); G Mounier (1); M Ollagnier (1); FRENCH NATIONAL MONITORING PROGRAMME AFTER ONE YEAR OF ZYBAN
Abstract complet
(1) Centre de Pharmacovigilance, CHU Saint-Etienne Bellevue, SAINT-ETIENNE;
Orale Lundi 14/04    2 O12 C Le Beller (1); S Henry (1); M Levée (2); G Derrien (3); C Le Maignan (4); E Levy (4); B Bonan (2); A Lillo-Le Louët (1); ASSESSMENT AFTER 12-MONTHS OF SYSTEMATIC REPORT OF CANCER TREATMENT ADVERSE DRUG REACTIONS
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Européen Georges Pompidou, PARIS; (2) Pharmacie, Hôpital Européen Georges Pompidou, PARIS; (3) Oncologie-Radiothérapie, Hôpital Européen Georges Pompidou, PARIS; (4) Oncologie Médicale, Hôpital Européen Georges Pompidou, PARIS;
Orale Lundi 14/04    2 O13 ML Laroche (1); M Amaniou (1); O Chaput (1); Y Nouaille (1); L Merle (1); CONSUMERS ASSOCIATION AND MEDICAL REPORTS ON CERIVASTATIN-INDUCED MUSCLE DISORDERS
Abstract complet
(1) Centre Régional de Pharmacovigilance, CHU Dupuytren, LIMOGES;
Orale Lundi 14/04    2 O14 R Serreau (1); A Liutkus (1); F Menez (2); V Baudouin (3); D Luton (4); E Jacqz-Aigrain (1); ADVERSE EFFECTS OF ACE INHIBITORS AND AT1 RECEPTOR BLOCKERS DURING PREGNANCY
Abstract complet
(1) Pharmacology Unit, Robert Debré Hospital, PARIS; (2) Foetopathology unit, Robert Debré Hospital, PARIS; (3) Nephrology Unit, Robert Debré Hospital, PARIS; (4) Gynecology-Obstetrics Unit, Robert Debré Hospital, PARIS;
Orale Lundi 14/04    2 O15 H Saissi (1); AP Jonville-Bera (1); F Beau-Salinas (1); G Lorette (2); E Autret-Leca (1); DRUG-INDUCED ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS
Abstract complet
(1) Centre Régional de Pharmacovigilance, CHRU Tours, TOURS; (2) Service de Dermatologie, CHRU, TOURS;
Orale Lundi 14/04    2 O16 K Martin (1); S Lawson-Ayayi (2); G Miremont-Salamé (1); MJ Blaizeau (3); D Lacoste (3); M Dupon (3); T Schaverberke (4); P Mercié (3); JM Ragnaud (3); F Haramburu (1); F Dabis (2); ASEPTIC OSTEONECROSIS IN HIV-INFECTED PATIENTS, AQUITAINE COHORT 1999 – 2002
Abstract complet
(1) Centre Régional de Pharmacovigilance, Département de Pharmacologie, Université Victor Segalen, CHU, BORDEAUX; (2) INSERM U330, Université Victor Segalen Bordeaux 2, BORDEAUX; (3) Centre d’Information et de Soins sur l’Immunodéficience Humaine, CHU, BORDEAUX; (4) Service de Rhumatologie, CHU, BORDEAUX;
Orale Lundi 14/04    2 O17 S Lugardon (1); K Desboeuf (2); P Fernet (2); JL Montastruc (1); M Lapeyre-Mestre (1); ASSESSING THE PREVALENCE OF ADVERSE DRUG REACTIONS IN A FRENCH UNIVERSITY HOSPITAL : A CAPTURE-RECAPTURE STUDY USING DATA FROM PMSI AND THE FRENCH PHARMACOVIGILANCE DATABASE
Abstract complet
(1) Service de Pharmacologie Clinique, Faculté de Médecine, TOULOUSE; (2) Fédération d’Informatique Médicale et d’Evaluation, CHU, TOULOUSE;
Orale Lundi 14/04    2 O18 G Pietri (1); E Van Ganse On Behalf Of The Euro-Med-Stat Group (1); EURO-MED-STAT: MONITORING EXPENDITURE AND UTILISATION OF MEDICINAL PRODUCTS IN THE EUROPEAN UNION COUNTRIES. A PUBLIC HEALTH APPROACH
Abstract complet
(1) Unité de Pharmacoépidémiologie, Centre Hospitalier Universitaire Lyon Sud, PIERRE-BENITE;
Orale Lundi 14/04    2 O19 P Mismetti (1); JM Yeguiayan (1); S Quenet (1); B Tardy (2); S Laporte (1); H Decousus (1); PHARMACOEPIDEMIOLOGY OF INITIAL ANTICOAGULANT THERAPY OF DEEP-VEIN THROMBOSIS: RISK ASSESSMENT OF MAJOR HAEMORRHAGES BASED ON INDIVIDUAL DATA FROM 5 RANDOMISED TRIALS
Abstract complet
(1) Unité Pharmacologie Clinique, EA3065, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (2) Service Urgences et Réanimation Médicale, EA3065, CHU Saint-Etienne Bellevue, SAINT-ETIENNE;
Orale Lundi 14/04    2 O20 E Rahme (1); AN Barkun (2); YM Toubouti (1); M Bardou (2); SPECIFIC COX-2 INHIBITORS ROFECOXIB AND CELECOXIB MAY PREVENT COLORECTAL ADENOMAS OCCURRENCE AND RECURRENCE. A NESTED CASE-CONTROL STUDY
Abstract complet
(1) Clinical Epidemiology Unit, McGill University Health Center, MONTREAL, CANADA; (2) Gastroenterology Department, McGill University Health Center, MONTREAL, CANADA;
Orale Mardi 15/04    7 O80 F Moritz (1); M Isabelle (1); C Monteil (1); F Bauer (1); P Mulder (1); V Richard (1); C Thuillez (1); ENHANCED OXIDATIVE STRESS AS A POTENTIAL MECHANISM UNDERLYING THE COCAINE-INDUCED CARDIAC DYSFUNCTION : PREVENTIVE EFFECT OF VITAMINS C AND E
Abstract complet
(1) INSERM E9920, Faculté de médecine, ROUEN;
Orale Mardi 15/04    7 O81 F Dupuis (1); P Limiñana (1); J Atkinson (1); JM Chillon (1); CAPTOPRIL ATTENUATES CEREBRAL ARTERIOLAR REMODELING AND DECREASES THE LOWER LIMIT OF CEREBRAL BLOOD FLOW AUTOREGULATION IN OLD SHR
Abstract complet
(1) Laboratoire de pharmacologie cardiovasculaire (EA3448), Faculté de Pharmacie, NANCY;
Orale Mardi 15/04    7 O82 R Tissier (1); K Aouam (1); A Berdeaux (1); B Ghaleh (1); PHARMACOLOGICAL DELAYED PRECONDITIONING AGAINST MYOCARDIAL INFARCTION: EVIDENCE FOR A “CEILING OF CARDIOPROTECTION”
Abstract complet
(1) Laboratoire de Pharmacologie et INSERM E 00.01, Faculté de Médecine Paris Sud, LE KREMLIN-BICETRE;
Orale Mardi 15/04    7 O83 S Pons (1); AA Hagege (2); P Meneton (2); JF Giudicelli (1); F Alhenc-Gelas (2); C Richer (1); PROTECTIVE ROLE OF THE KALLIKREIN-KININ SYSTEM IN POST-ISCHEMIC CONGESTIVE HEART FAILURE IN MICE
Abstract complet
(1) Laboratoire de Pharmacologie et INSERM E 00.01, Faculté de Médecine Paris Sud, LE KREMLIN-BICETRE; (2) INSERM U367, Rue du Fer à Moulin, PARIS;
Orale Mardi 15/04    7 O84 M Billing-Grima (1); J Anjuere (1); J Steger (1); C Bourdenet-Coquard (1); JL Imbs (2); INTERNALIZATION OF ANGIOTENSIN II IN THE KIDNEYS IN HYPERTENSIVE TWO-KIDNEY, ONE-CLIP RATS
Abstract complet
(1) Institut de Pharmacologie, Faculté de Médecine Université Louis Pasteur, STRASBOURG; (2) Service d’Hypertension, Maladies Vasculaires et Pharmacologie Clinique, Hôpitaux Universitaires de Strasbourg, STRASBOURG;
Orale Mardi 15/04    7 O85 L Monassier (1); C Bellocq (2); J Weissenburger (3); H Greney (1); D Zimmermann (1); JD Ehrardt (1); I Baro (2); P Bousquet (1); INVOLVEMENT OF MYOCARDIAL SIGMA-2 RECEPTORS IN CARDIAC REPOLARIZATION
Abstract complet
(1) Laboratoire de Neurobiologie et Pharmacologie Cardiovasculaire, Faculté de Médecine, STRASBOURG; (2) INSERM U533, Hôpital Hôtel-Dieu, NANTES; (3) Laboratoire de Pharmacologie, Hôpital Saint-Antoine, PARIS;
Orale Mardi 15/04    7 O86 C Loichot (1); L Jesel (1); A Tabernero (1); K Schoonjans (2); G Roul (1); 1I Carpusca (1); J Auwerx (2); R Andriantsitohaina (1); DELETION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA TRIGGERS A CARDIOMYOPATHY WITH AN INCREASED SUCEPTIBILITY TO MYOCARDIAL ISCHAEMIC INJURY
Abstract complet
(1) UMR CNRS 7034, Faculté de pharmacie, ILLKIRCH; (2) IGBMC, 1rue Laurent Friesl, ILLKIRCH;
Orale Mardi 15/04    7 O87 F Boutitie (1); F Gueyffier (2); JP Boissel (2); R Ecochard (1); METHODOLOGICAL ISSUES ON THE VALIDATION OF SYSTOLIC BLOOD PRESSURE AS A SURROGATE MARKER OF THE EFFECT OF ANTI-HYPERTENSIVE TREATMENTS ON THE REDUCTION OF THE RISK OF STROKE
Abstract complet
(1) Service de Biostatistique, Hospices Civils de Lyon, LYON; (2) Service de pharmacologie clinique EA643, Université Claude Bernard, LYON;
Orale Mardi 15/04    7 O88 V Leblais (1); F Pourageaud (1); R Marthan (2); B Muller (1); EVIDENCE FOR CONTRIBUTION OF ALPHA-ADRENOCEPTORS IN THE EFFECTS OF CGP12177 IN RAT PULMONARY ARTERIES
Abstract complet
(1) Laboratoire de Pharmacologie – INSERM EMI 9937, Faculté de Pharmacie, BORDEAUX; (2) INSERM EMI 9937, Faculté de Médecine, BORDEAUX;
Orale Mardi 15/04    7 O89 V Richard (1); S Hurel (1); PY Litzler (2); E Scalbert (3); JP Bessou (2); C Thuillez (1); LACK OF FUNCTIONAL ROLE OF VASCULAR CHYMASE IN THE PRODUCTION OF ANGIOTENSIN II IN ISOLATED HAMSTER ARTERIES. COMPARISON WITH HUMAN VESSELS
Abstract complet
(1) INSERM E9920, Faculté de médecine, ROUEN; (2) Service de Chirurgie Cardiaque, CHU, ROUEN; (3) IRIS, 6 Place des Pléiades, COURBEVOIE;
Orale Mardi 15/04    8 O90 C Renard (1); BA Nic Dhonnchadha (1); M Hascoët (1); P Jolliet (1); M Bourin (1); IS DOPAMINE A LIMITING FACTOR IN ANTIDEPRESSANT-LIKE STUDIES IN THE FST?
Abstract complet
(1) EA 3256 Neurobiologie de l’anxiété et de la dépression, Faculté de Médecine, NANTES;
Orale Mardi 15/04    8 O91 I Masse (1); R Bordet (1); A Al Khedr (2); D Deplanque (1); F Pasquier (2); C Libersa (3); COGNITIVE DECLINE WITH ALZHEIMER DISEASE (AD) AND FIBRATES : A BENEFIT ASSOCIATION ?
Abstract complet
(1) EA 1046, Hôpital Huriez CHRU Lille, LILLE; (2) EA 2691, Hôpital Roger Salengro CHRU Lille, LILLE; (3) EA 1046, CIC INSERM 9301, Hôpital Huriez, Hôpital Cardiologique CHRU Lille, LILLE;
Orale Mardi 15/04    8 O92 D David (1); M Bourin (1); G Jego (2); C Przybylski (2); P Jolliet (1); AM Gardier (2); EFFECTS OF CHRONIC PAROXETINE AND CITALOPRAM TREATMENT BY DUAL IN VIVO APPROACHES: A INTRACEREBRAL MICRODIALYSIS AND A BEHAVIOURAL STUDIES IN AWAKE SWISS MICE
Abstract complet
(1) EA 3256 Neurobiologie de l’anxiété et de la dépression, Faculté de Médecine, NANTES; (2) EA 3544 Lab. Neuropharmacologie, Faculté de Pharmacie Université Paris-Sud, CHATENAY-MALABRY;
Orale Mardi 15/04    8 O93 V Beray-Berthat (1); N Croci (1); M Plotkine (1); I Margaill (1); ROLE OF POLYMORPHONUCLEAR NEUTROPHILS IN CEREBRAL ISCHEMIA-REPERFUSION IN RATS
Abstract complet
(1) UPRES EA 2510 Laboratoire de Pharmacologie, Faculté de Pharmacie, Université Paris V, PARIS;
Orale Mardi 15/04    8 O94 O Pétrault (1); M Bastide (1); N Cotelle (2); M Laprais (1); J Vamecq (1); P Duriez (3); R Bordet (1); ANTIOXIDANTS-INDUCED PROTECTION OF CEREBRAL BLOOD VESSELS FUNCTION AFTER ISCHEMIA/REPERFUSION (I/R)
Abstract complet
(1) Laboratoire de Pharmacologie, Faculté de Médecine de Lille 2, LILLE; (2) UPRESA 8009, Université de Lille1, VILLENEUVE D’ASCQ; (3) INSERM U545, Institut Pasteur de Lille, LILLE;
Orale Mardi 15/04    8 O95 B Le Foll (1); J Diaz (2); G Villafane (3); P Cesaro (3); A Mimran (3); M Marques (3); G Lagrue (4); S Ferry (1); V Mignon (1); P Sokoloff (1); NICOTINE ET RECEPTEUR D3 DE LA DOPAMINE : IMPLICATIONS DANS LA DEPENDANCE ET LA MALADIE DE PARKINSON
Abstract complet
(1) INSERM U573, 2 ter rue d’Alésia, PARIS; (2) Laboratoire de Physiologie, Faculté de Pharmacie, PARIS; (3) Service de Neurologie, Hopital Henri Mondor, CRETEIL; (4) Service de Tabacologie, Hopital Albert Chenevier, CRETEIL;
Orale Mardi 15/04    8 O96 G Michel (1); L Gueyrard (2); M Bongrand (1); B Michel (2); EFFICACY OF ACETYLCHOLINESTERASE INHIBITORSIN LEWY BODIES DEMENTIA
Abstract complet
(1) Pharmacie, Hôpital de la Conception, MARSEILLE; (2) Service de neurogeriatrie, Hôpital Sainte Marguerite, MARSEILLE;
Orale Mardi 15/04    8 O97 B Guiard (1); S Seyler (1); A Gardier (1); SUSTAINED BLOCKADE OF NEUROKININ-1 RECEPTORS MODIFIES 5-HT1A AUTORECEPTOR ACTIVITY: AN IN VIVO INTRACEREBRAL MICRODIALYSIS STUDY IN MICE
Abstract complet
(1) EA 3544 Lab. Neuropharmacologie, Faculté de Pharmacie Université Paris-Sud, CHATENAY-MALABRY;
Orale Mardi 15/04    8 O98 P Gele (1); D Deplanque (1); I Six (1); S Nion (2); JC Fruchart (3); R Ceccheli (2); B Staels (3); P Duriez (3); R Bordet (1); PROPHYLACTIC PPAR-ALPHA ACTIVATION DECREASES BRAIN INJURY AFTER TRANSIENT ISCHEMIA IN MICE
Abstract complet
(1) Laboratoire de Pharmacologie, Faculté de Médecine de Lille 2, LILLE; (2) Faculté des Sciences Jean Perrin, Université d’Artois, LENS; (3) INSERM U 545, Institut Pasteur de Lille, Fac. de Pharma. Lille2, LILLE;
Orale Mardi 15/04    8 O99 F Noble (1); J Salzmann (1); J Wilson (1); M Mas Nieto (1); BP Roques (1); IMBALANCE IN ENDOGENOUS CCK/OPIOID SYSTEMS MAY BE INVOLVED IN VULNERABILITY TO DRUG DEPENDENCE
Abstract complet
(1) INSERM U266, CNRS FRE 2463, Université René Descartes, PARIS;
Orale Mardi 15/04    9 O100 JM Treluyer (1); G Bowers (2); N Cazaali (1); E Rey (1); M Sonnier (3); G Pons (1); T Cresteil (3); EVALUATION OF THE MATURATION OF HUMAN CYP ON THE OXIDATIVE METABOLISM OF AMPRENAVIR
Abstract complet
(1) Pharmacologie, Hôpital Cochin Saint Vincent de Paul, PARIS; (2) GSK, GSK, NC, USA; (3) ICSN, CNRS, GIF SUR YVETTE;
Orale Mardi 15/04    9 O101 N Picard (1); T Cresteil (2); Y Le Meur (3); P Marquet (1); IDENTIFICATION OF A NEW PHASE I METABOLITE OF MYCOPHENOLIC ACID AND METABOLIC PATHWAY INVOLVED
Abstract complet
(1) Service de Pharmacologie et Toxicologie, CHU, LIMOGES; (2) ICSN, CNRS UPR 2301, GIF-SUR-YVETTE; (3) Service de néphrologie, CHU, LIMOGES;
Orale Mardi 15/04    9 O102 R Serreau (1); M Fakhoury (1); Y Medard (1); AL Delezoide (2); M Peuchmaur (3); E Jacqz-Aigrain (1); EXPRESSION OF CYP3A AND PGP IN HUMAN PLACENTA : A PROSPECTIVE CONTROLLED STUDY
Abstract complet
(1) Pharmacology Unit, Robert Debré Hospital, PARIS; (2) Foetopathology unit, Robert Debré Hospital, PARIS; (3) Anatomo-pathology Unit, Robert Debré Hospital, PARIS;
Orale Mardi 15/04    9 O103 K Lacut (1); E Oger (1); M Alhenc-Gelas (2); V Kerlan (3); N Roudaut (3); M Collet (4); M Aïach (5); PY Scarabin (2); D Mottier (1); DIFFERENTIAL EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN/PROGESTERONE REGIMENS ON SENSITIVITY TO ACTIVATED PROTEIN C AMONG POSTMENOPAUSAL WOMEN: A RANDOMISED (S.A.R.A.H) TRIAL
Abstract complet
(1) Département de Médecine Interne et Pneumologie, CHU Cavale Blanche, BREST; (2) Unité INSERM 258, Hôpital Paul Brousse, VILLEJUIF; (3) Service d’Endocrinologie, CHU Cavale Blanche, BREST; (4) Service de Gynécologie, CHU Morvan, BREST; (5) Laboratoire d’Hématologie, Hôpital Européen Georges Pompidou, PARIS;
Orale Mardi 15/04    9 O104 C Moro (1); J Galitzky (1); C Sengenès (1); F Crampes (1); I De Glisezinski (1); C Thalamas (2); M Lafontan (1); M Berlan (1); EVIDENCE FOR A NON-ADRENERGIC LIPOLYSIS IN HUMAN SUBCUTANEOUS ADIPOSE TISSUE DURING EXERCISE: PUTATIVE ROLE OF NATRIURETIC PEPTIDES.
Abstract complet
(1) INSERM U317, Faculté de Médecine, TOULOUSE; (2) CIC, CHU Purpan, TOULOUSE;
Orale Mardi 15/04    9 O105 C Delayre-Orthez (1); S Demesy (1); E Mathieu (1); N Frossard (1); F Pons (1); EXPOSURE TO ENDOTOXIN EXHIBITS DUAL AND DOSE-DEPENDENT EFFECTS ON ALLERGEN SENSITIZATION AND CHALLENGE IN A MOUSE MODEL OF ASTHMA
Abstract complet
(1) INSERM U425, Faculté de pharmacie, ILLKIRCH;
Orale Mardi 15/04    9 O106 C Rouget (1); YY Cui (1); E Naline (1); M Bardou (1); C Advenier (1); NOCICEPTIN INHIBITS AIRWAY MICROVASCULAR LEAKAGE INDUCED BY HCL INTRA-OESOPHAGEAL INSTILLATION
Abstract complet
(1) UPRES EA220, UFR Biomédicale des Saints Pères, PARIS;
Orale Mardi 15/04    9 O107 M Bardou (1); YM Toubouti (2); D Benhaberou-Brun (1); E Rhame (2); AN Barkun (1); HIGH DOSE INTRAVENOUS PROTON PUMP INHIBITION DECREASE BOTH RE-BLEEDING AND MORTALITY IN HIGH-RISK PATIENTS WITH ACUTE PEPTIC ULCER BLEEDING: A SERIES OF META-ANALYSES
Abstract complet
(1) Gastroenterology Department, McGill University Health Center, MONTREAL, CANADA; (2) Clinical Epidemiology Unit, McGill University Health Center, MONTREAL, CANADA;
Orale Mardi 15/04    9 O108 S Gautier (1); O Petrault (1); D Deplanque (1); J Caron (1); R Bordet (1); ROLE OF THROMBUS LYSIS AND VASCULAR WALL IMPAIRMENT IN RTPA-INDUCED CEREBRAL HEMORRHAGE DURING STROKE
Abstract complet
(1) Pharmacologie EA1046, Faculté de Médecine, LILLE;
Orale Mardi 15/04    9 O109 A Tabernero (1); R Andriantsitohaina (1); S Chasserot (2); CD Muller (1); JM Reimund (3); CYCLOOXYGENASE (COX)-2 (COX-2) EXPRESSION AND ROLE OF VASOCONSTRICTOR PROSTANOIDS IN SMALL MESENTERIC ARTERIES (SMA) FROM PATIENTS WITH CROHN’S DISEASE (CD)
Abstract complet
(1) CNRS UMR 7034, Faculté de pharmacie, ILLKIRCH; (2) CNRS UPR 2356, Strasbourg, STRASBOURG; (3) Hépato-Gastroentérologie & Assistance Nutritive, Hôpitaux Universitaires de Strasbourg, STRASBOURG;
Poster Lundi 14/04   P21 C Victorri-Vigneau (1); D Oliveira (1); M Bourin (1); P Jolliet (1); RISK PERCEPTION AND PHARMACOVIGILANCE SELF MEDICATION : AN OPINION SURVEY DROWN ON CONSUMERS AND PHARMACISTS
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie 9 quai Moncousu, NANTES;
Poster Lundi 14/04   P22 M Bronnec (1); B Guitton (2); M Bourin (1); P Jolliet (1); METABOLIC DISTURBANCES ASSOCIATED WITH ATYPICAL ANTIPSYCHOTICS
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie 9 quai Moncousu, NANTES; (2) Service de Psychiatrie Hospitalo-Universitaire, Hôpital Saint Jacques – CHU, NANTES;
Poster Lundi 14/04   P23 M Bronnec (1); E Lolarge (2); R Bocher (2); M Bourin (1); P Jolliet (1); CLOZAPINE-INDUCED NEUTROPHILIA : A RARE HEMATOLOGICAL SIDE-EFFECT
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie 9 quai Moncousu, NANTES; (2) Service de Psychiatrie V, Hôpital Saint Jacques – CHU, NANTES;
Poster Lundi 14/04   P24 A Chiffoleau (1); D Drui (2); G Veyrac (1); Y Cariou (1); JM Chavigny (3); B Milpied (4); M Bourin (1); P Jolliet (1); ALLERGY TO BETA BLOCKERS OR ALLERGY REVEALED BY BETA BLOCKERS ? CASE REPORT AND ITS ALLERGIC CROSS REACTION THERAPEUTIC MANAGEMENT
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie 9 quai Moncousu, NANTES; (2) Clinique cardiologique et des maladies vasculaires, CHU, NANTES; (3) Centre Médical Sud Loire Mauvoisins, Rue Mauvoisins, NANTES; (4) Service de Dermatologie, CHU, NANTES;
Poster Lundi 14/04   P25 A Chiffoleau (1); T Ponge (2); G Veyrac (1); F Pajot (1); J Barrier (2); M Bourin (1); P Jolliet (1); HYDROXYCARBAMIDE (HYDREA®) AND GEANT NECROTIC ULCERATIONS IN AN OLD THROMBOCYTEMIC PATIENT
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie 9 quai Moncousu, NANTES; (2) Service de Médecine Interne, CHU, TOULOUSE;
Poster Lundi 14/04   P26 CH Ben Salem (1); J Michot (1); V Pras (1); S Makki (1); M Biour (1); DRUG-INDUCED ACUTE PANCREATITIS: AN UPDATED DATABASE
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Saint-Antoine, PARIS;
Poster Lundi 14/04   P27 G Mounier (1); C Guy (1); MN Beyens (1); M Ratrema (1); M Ollagnier (1); FLURBIPROFEN-INDUCED ACUTE RENAL FAILURERESULTS OF THE FRENCH POST-MARKETING SURVEILLANCE
Abstract complet
(1) Centre de Pharmacovigilance, CHU Saint-Etienne Bellevue, SAINT-ETIENNE;
Poster Lundi 14/04   P28 G Durrieu (1); E Gorsse (1); J Montastruc (1); NEWSPAPERS : SOURCE OF INFORMATION ABOUT DOPING IN SPORTS
Abstract complet
(1) Service de Pharmacologie Clinique, Antenne Méd de Lutte Dopage, Faculté de Médecine, TOULOUSE;
Poster Lundi 14/04   P29 G Veyrac (1); F Briec (2); A Chiffoleau (1); H Villain (1); H Le Marec (2); M Bourin (1); P Jolliet (1); DILATED CARDIOMYOPATHY AFTER CHRONIC TREATMENT WITH TRICYCLIC ANTIDEPRESSANT DRUGS
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie 9 quai Moncousu, NANTES; (2) Clinique cardiologique et des maladies vasculaires, CHU, NANTES;
Poster Lundi 14/04   P30 G Veyrac (1); MT Legall (2); A Chiffoleau (1); M Bourin (1); P Jolliet (1); PROLONGED BLEEDING TIME BY PAROXETINE (DEROXAT®)
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie 9 quai Moncousu, NANTES; (2) Allée R.Rolland, Rézé, REZE;
Poster Lundi 14/04   P31 T Trenque (1); F Cardona (1); A Molia (1); H Millart (1); ML Germain (1); INTRADISCAL CALCIFICATION WITH INTRADISCAL INJECTION OF GLUCOCORTICOIDS
Abstract complet
(1) Centre Régional de Pharmacovigilance, Centre Hospitalier Universitaire, REIMS;
Poster Lundi 14/04   P32 A Molia (1); A Delcourt (2); MA Preiss (2); ML Germain (1); T Trenque (1); EPOETIN : A DOSE-DEPENDENT MARKED THROMBOCYTOSIS ?
Abstract complet
(1) Centre Régional de Pharmacovigilance, Centre Hospitalier Universitaire, REIMS; (2) Service de Cardiologie, Centre Hospitalier, SAINT-DIZIER;
Poster Lundi 14/04   P33 F Cardona (1); G Jolimoy (2); C Kreft-Jaïs (2); T Trenque (1); IMPROVING REPORTING OF ADVERSE EVENTS RELATED TO ANTICANCER DRUGS TREATMENT
Abstract complet
(1) Centre Régional de Pharmacovigilance, Centre Hospitalier Universitaire, REIMS; (2) Unité de Pharmacovigilance, AFSSAPS, SAINT DENIS;
Poster Lundi 14/04   P34 AP Jonville-Bera (1); F Tauveron (1); L Bensouda (1); F Beau-Salinas (1); E Autret-Leca (1); EXTRAPYRAMIDAL REACTIONS FROM CURRENT SSRI AND NEUROLEPTIC USE
Abstract complet
(1) Centre Régional de Pharmacovigilance, CHRU, TOURS;
Poster Lundi 14/04   P35 M Ollagnier (1); P Caton (2); B Trombert (3); C Guy (1); P Beck (2); GASTROINTESTINAL HAEMORRHAGES AND NSAIDS : A PROSPECTIVE STUDY
Abstract complet
(1) Centre de Pharmacovigilance, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (2) URCAM-CPAM de St-Etienne, 3 Avenue du Président Emile Loubet, SAINT-ETIENNE; (3) Service de Santé Publique (S.S.P.I.M.), Hôpital de Saint-Jean-Bonnefonds, SAINT-JEAN-BONNEFONDS;
Poster Lundi 14/04   P36 I Heran (1); MP Louis (1); H Peyriere (1); D Hillaire-Buys (1); JP Blayac (1); TWO CASES OF GYNECOMASTIA IN CHILDREN TREATED WITH CETIRIZINE, A SECOND GENERATION ANTIHISTAMINE
Abstract complet
(1) Service de Pharmacologie Médicale et Toxicologie, Hôpital Lapeyronie, MONTPELLIER;
Poster Lundi 14/04   P37 J Micallef (1); S Tardieu (1); K Khalech (1); O Blin (1); BENZODIAZEPINE AND HICCUPS : THREE CASE REPORTS
Abstract complet
(1) CPCET & Service de Pharmacologie Clinique, CHU Timone, MARSEILLE;
Poster Lundi 14/04   P38 O Maillard (1); C Guy (1); M Burellier (2); MN Beyens (1); M Ratrema (1); G Mounier (1); D Michel (3); M Ollagnier (1); REVERSIBLE DEMENTIA ASSOCIATED WITH VALPROIC ACID MONOTHERAPY
Abstract complet
(1) Centre Régional de Pharmacovigilance, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (2) 11 Avenue de la prairie, , CRAPONNE SUR ARZON; (3) Service de Neurologie, CHU Saint-Etienne Bellevue, SAINT-ETIENNE;
Poster Lundi 14/04   P39 V Pinzani (1); D Hillaire-Buys (1); S Petiot (2); H Peyrière (1); N Mirfendereski (1); JP Blayac (1); ETONOGESTREL AND HEMORRHAGIC STROKE: A CASE REPORT
Abstract complet
(1) Service de Pharmacologie Médicale et Toxicologie, Hôpital Lapeyronie, MONTPELLIER; (2) Département de Médecine Physique et Réadaptation, Hôpital Caremeau, NIMES;
Poster Lundi 14/04   P40 C Cabou (1); H Bagheri (1); A Cantagrel (2); B Mazière (2); JL Montastruc (1); RETROSPECTIVE ANALYSIS OF ADVERSE REACTIONS OF INFLIXIMAB IN A DEPARTMENT OF RHUMATOLOGY
Abstract complet
(1) Service de Pharmacologie Clinique, Faculté de Médecine-CHU, TOULOUSE; (2) Service de Rhumatologie, CHU Rangueil, TOULOUSE;
Poster Lundi 14/04   P41 ML Hemery (1); V Pinzani (1); P Quittet (2); V Faucherre (3); C Janbon (4); JP Blayac (1); THROMBOEMBOLIC COMPLICATIONS AND INTERFERON ALFA 2B THERAPY
Abstract complet
(1) Pharmacologie Médicale et Toxicologie, Hôpital Lapeyronie, MONTPELLIER; (2) Hématologie, Hôpital Lapeyronie, MONTPELLIER; (3) Médecine F, Hôpital Saint-Eloi, MONTPELLIER; (4) Médecine B, Hôpital Saint-Eloi, MONTPELLIER;
Poster Lundi 14/04   P42 P Lochet (1); V Faucherre (2); V Pinzani (1); ML Hemery (1); D Hillaire Buys (1); JP Blayac (1); REVERSIBLE INSULIN-DEPENDENT DIABETES MELLITUS ASSOCIATED WITH INTERFERON THERAPY IN A CHRONIC HEPATITIS C PATIENT
Abstract complet
(1) Pharmacologie Médicale et Toxicologie, Hôpital Lapeyronie, MONTPELLIER; (2) Médecine Interne F, Hôpital Saint Eloi, MONTPELLIER;
Poster Lundi 14/04   P43 N Mirfendereski (1); P Lochet (1); A Gauthey-abderrahim (1); V Pinzani (1); D Hillaire-Buys (1); JP Blayac (1); LAUROMACROGOL AND TRANSIENT NEUROLOGIC DISORDERS
Abstract complet
(1) Service de Pharmacologie, Hôpital Lapeyronie, MONTPELLIER;
Poster Lundi 14/04   P44 ML Laroche (1); F Macian-Montoro (2); L De Lumley (3); M Amaniou (1); M Lacoste (2); L Merle (1); CEREBRAL ISCHEMIA AND ISOTRETINOIN : TWO CASE REPORTS
Abstract complet
(1) Centre Régional de Pharmacovigilance, CHU Dupuytren, LIMOGES; (2) Service de Neurologie, CHU Dupuytren, LIMOGES; (3) Département de Pédiatrie Médicale, CHU Dupuytren, LIMOGES;
Poster Lundi 14/04   P45 C Lafay (1); C Cordonnier (1); C Remblier (1); MC Perault (1); NON CONFORMITY IN PHARMACOVIGILANCE
Abstract complet
(1) Service de Pharmacologie Clinique-CRPV, CHU, POITIERS;
Poster Lundi 14/04   P46 D Raylet (1); C Lafay (1); S Favreliere (1); B Dreyfus (2); MC Perault (1); RABEPRAZOLE INDUCED ERYTHEMA NODOSUM
Abstract complet
(1) Service de Pharmacologie Clinique-CRPV, CHU, POITIERS; (2) Service d’Hématologie de Jour, CHU, POITIERS;
Poster Lundi 14/04   P47 L Chauvelot-Moachon (1); M De Menton (2); S Abad (2); C Vauzelle (1); F Bavoux (1); P Blanche (2); TRAMADOL, WITH THE ANTIDEPRESSANTS INHIBITORS OF SEROTONIN REUPTAKE, INDUCE A SEROTONIN SYNDROME
Abstract complet
(1) Pharmacovigilance, Faculté de Médecine et Hôpital Cochin, PARIS; (2) Médecine Interne, Hôpital Cochin, PARIS;
Poster Lundi 14/04   P48 C Remblier (1); G Desprairies (2); C Lafay (1); MC Perault (1); ORIGINAL ANGIOGRAPHIC PATTERN AND EDEMA RELATED TO METHYSERGIDE
Abstract complet
(1) CRPV-Service de Pharmacologie Clinique, CHU, POITIERS; (2) Médecine-Angiologie, Libéral, LA ROCHELLE;
Poster Lundi 14/04   P49 V Gras-Champel (1); H Masson (1); C Lematte (1); P Pakula (1); B Roussel (2); K Masmoudi (1); M Andréjak (1); ASSESSMENT OF ORAL ANTICOAGULATION MANAGEMENT QUALITY AMONG PATIENTS ADMITTED TO THE AMIENS UNIVERSITY HOSPITAL
Abstract complet
(1) Pharmacovigilance Centre, CHU Amiens Sud, AMIENS; (2) Haematology laboratory, CHU Amiens Nord, AMIENS;
Poster Lundi 14/04   P50 C Remblier (1); C Pradère (2); S Favrelière (1); MC Perault (1); POSSIBLE SEROTONIN SYNDROME ASSOCIATED WITH FLUOXETINE AND HYDROMORPHONE COADMINISTRATION
Abstract complet
(1) CRPV-Service de Pharmacologie Clinique, CHU, POITIERS; (2) Soins de Suite D, CHU, POITIERS;
Poster Lundi 14/04   P51 AC Resende (1); S Faure (1); S Nadaud (2); I Lartaud-Idjouadiène (1); J Atkinson (1); C Capdeville-Atkinson (1); MELATONIN ATTENUATES THE DECREASE IN NORADRENALINE (NA)-INDUCED CONTRACTION OF RAT AORTIC RINGS PRODUCED BY PROLONGED INCUBATION
Abstract complet
(1) EA 3448, Faculté de Pharmacie, NANCY; (2) INSERM 525, 91 bd de l’Hôpital, PARIS;
Poster Lundi 14/04   P52 A Rupin (1); J R Paysant (1); T J Verbeuren (1); ANOXIA/REOXYGENATION AND AN INFLAMMATORY CONTEXT SYNERGISTICALLY INCREASE E-SELECTIN EXPRESSION THROUGH NADPH OXIDASE IN HUVECS
Abstract complet
(1) Division Angiologie, Institut de Recherche Servier, SURESNES;
Poster Lundi 14/04   P53 K Chalupsky (1); I Lobysheva (2); G Entlicher (3); F Nepveu (2); JC Stoclet (1); B Muller (4); N-HYDROXYLATED COMPOUNDS AS SUBSTRATES FOR NO PRODUCTION IN BLOOD VESSELS
Abstract complet
(1) Pharmacologie et Physicochimie, CNRS UMR 7034, Faculté de Pharmacie, Université Louis Pasteur, ILLKIRCH; (2) Pharmacophores Redox Phytochimie & Radiobiologie, EA-3030, Faculté de Pharmacie, Université Paul Sabatier, TOULOUSE; (3) Departement of Biochemistry, Charles University, PRAGUE, TCHEQUIE; (4) Pharmacologie INSERM EMI 9937, Faculté de Pharmacie, Université Victor Segalen, BORDEAUX;
Poster Lundi 14/04   P54 P Guerard (1); O Barthez (1); F Goirand (2); L Rochette (1); JP Dumas (1); M Dumas (1); M Bardou (1); THE HMG-COA REDUCTASE INHIBITOR, PRAVASTATIN, PREVENTS THE DEVELOPMENT OF MONOCROTALINE-INDUCED PULMONARY HYPERTENSION IN THE RAT
Abstract complet
(1) LPPCE, Faculté de médecine, DIJON; (2) Laboratoire de Physiologie, Faculté de pharmacie, CHATENAY-MALABRY;
Poster Lundi 14/04   P55 J Paysant (1); A Rupin (1); P Sansilvestri-Morel (1); N Lembrez (1); T Verbeuren (1); ANOXIA/REOXYGENATION INDUCED A NADPH OXIDASE DEPENDENT OXIDATIVE STRESS IN ENDOTHELIAL CELLS WHICH OVEREXPRESSED E-SELECTIN VIA NFKB ACTIVATION
Abstract complet
(1) Division Angiologie, Institut de Recherche Servier, SURESNES;
Poster Lundi 14/04   P56 S Simonet (1); C Badier Commander (1); J R Paysant (1); C Vayssettes Courchay (1); A Rupin (1); Y Menant (1); C Hennape (1); G Gautier (1); T J Verbeuren (1); EFFECTS OF NADH AND NADPH IN RABBIT AORTA : SIGNALLING PATHWAY AND COMPARISON WITH EFFECTS NOTED IN RABBIT SAPHENOUS VEIN
Abstract complet
(1) Division Angiologie, Institut de Recherche Servier, SURESNES;
Poster Lundi 14/04   P57 F Pourageaud (1); V Leblais (1); R Marthan (2); B Muller (1); PHENOXYBENZAMINE PRE-TREATMENT REVEALS AN ATYPICAL BETA-ADRENERGIC RELAXATION IN RAT INTRAPULMONARY ARTERIES
Abstract complet
(1) Laboratoire Pharmacologie, INSERM EMI9937, Faculté de Pharmacie, BORDEAUX; (2) Laboratoire de Physiologie, INSERM EMI9937, Faculté de Médecine, BORDEAUX;
Poster Lundi 14/04   P58 N Ryckelynck (1); C Laurent (1); R Morello (2); B Mosquet (1); J Lacotte (1); E Singlas (3); A Coquerel (1); OBSERVATIONAL STUDY ABOUT GENERIC DRUGS USE IN BASSE NORMANDIE (ACHIEVED DURING 2001) AMONG FIVE HUNDRED GENERAL PRACTITIONERS
Abstract complet
(1) Pharmacovigilance, CHU, CAEN; (2) Informatique Medicale, CHU, CAEN; (3) Chimie Thérapeutique, Faculté de Pharmacie, Université de Caen, CAEN;
Poster Lundi 14/04   P59 A Umar (1); F Depont (1); A Jacquet (1); S Lignot (1); B Bégaud (1); MC Segur (2); M Boisseau (3); N Moore (1); EFFECTS OF ARMAGNAC OR VODKA ON PLATELET AGGREGATION IN HEALTHY VOLUNTEERS: A RANDOMIZED CLINICAL TRIAL
Abstract complet
(1) Pharmacologie, Université Victor Segalen Bordeaux 2, BORDEAUX; (2) BNIA, EAUZE; (3) Hématologie, CHU Bordeaux, BORDEAUX;
Poster Lundi 14/04   P60 M Billing-Grima (1); J Anjuere (1); J Steger (1); C Bourdenet-Coquard (1); JL Imbs (2); RELATION BETWEEN PLASMA ANGIOTENSIN II AND TISSUE INTERNALIZATION VIA THE AT1 RECEPTOR
Abstract complet
(1) Institut de Pharmacologie, Faculté de Médecine Université Louis Pasteur, STRASBOURG; (2) Service de Maladies Vasculaires, Hypertesion et Pharmacologie clinique, Hôpitaux Universitaires de Strasbourg, STRASBOURG;
Poster Lundi 14/04   P61 M Barthelmebs (1); N Wiernsperger (2); JR Rapin (3); M Grima (4); JL Imbs (4); METFORMIN ACCUMULATION IN THE KIDNEY OF DIABETIC RATS DOES NOT ALTER RENAL FUNCTION NOR WORSEN IT DURING ACUTE RENAL FAILURE
Abstract complet
(1) INSERM E0015, Faculté de Médecine, STRASBOURG; (2) Merck-Lipha, 37 rue Saint-Romain, LYON; (3) Dospharma, 3 rue du Tronquet, MONT SAINT AIGNAN; (4) Institut de Pharmacologie, Faculté de Médecine, STRASBOURG;
Poster Lundi 14/04   P62 M Diebolt (1); L Germain (2); F Auger (2); R Andriantsitohaina (1); HUMAN TISSUE-ENGINEERED VASCULAR MEDIA AS A PHARMACOLOGICAL TOOL TO STUDY THE REGULATION OF CONTRACTION BY POLYPHENOLS
Abstract complet
(1) UMR CNRS 7034, Faculté de pharmacie, ILLKIRCH; (2) Laboratoire d’organogénèse expérimental, Université de Laval, QUEBEC, CANADA;
Poster Lundi 14/04   P63 L Guedon-Moreau (1); JL Gayet (2); Y Frances (3); M Galinier (4); H Lardoux (5); C Libersa (1); INCIDENCE OF ADVERSE EVENTS AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION IN EPCAF STUDY
Abstract complet
(1) Pharmacologie, CHRU LILLE, LILLE; (2) -, COLOMBES; (3) Cardiologie, Hôpital Nord, MARSEILLE; (4) Cardiologie, CHU Rangueil, TOULOUSE; (5) Cardiologie, Groupe Hospitalier Sud Francilien, CORBEIL ESSONNES;
Poster Lundi 14/04   P64 S Davani (1); A Marandin (2); N Mersin (3); B Royer (1); H Reyssie (1); B Kantelip (4); JP Kantelip (1); MESENCHYMAL PROGENITOR CELLS DIFFERENTIATE TO AN ENDOTHELIAL PHENOTYPE, ENHANCE VASCULAR DENSITY AND IMPROVE HEART FUNCTION IN A RAT CELLULAR CARDIOMYOPLASTY MODEL
Abstract complet
(1) Pharmacologie-EA479, CHU Jean Minjoz, BESANÇON; (2) EFS-EA2284, Etablissement Français du Sang, BESANÇON; (3) Chirurgie Cardiovasculaire et Thoracique-EA479, CHU Jean Minjoz, BESANÇON; (4) Anatomopathologie-EA479, CHU Jean Minjoz, BESANÇON;
Poster Lundi 14/04   P65 JS Hulot (1); JL Démolis (1); R Rivière (1); S Strabach (1); S Christin-Maitre (2); C Funck-Brentano (1); ABSENCE OF INFLUENCE OF ENDOGENOUS ESTROGENS ON QT INTERVAL DURATION
Abstract complet
(1) Centre d’investigation clinique, Hôpital Saint-Antoine, PARIS; (2) Service d’Endocrinologie, Hôpital Saint-Antoine, PARIS;
Poster Lundi 14/04   P66 A Umar (1); M Boisseau (2); MC Segur (3); N Moore (1); EFFECT OF AGE OF ARMAGNAC EXTRACT AND DURATION OF TREATMENT ON ANTITHROMBOTIC EFFECTS IN A RAT THROMBOSIS MODEL
Abstract complet
(1) Pharmacologie, Université Victor Segalen Bordeaux 2, BORDEAUX; (2) Hématologie, Université Victor Segalen Bordeaux 2, BORDEAUX; (3) BNIA, EAUZE;
Poster Lundi 14/04   P67 P Philip-Couderc (1); A Pathak (1); F Smih (1); JM Senard (1); X Collet (2); F Tercet (2); M Galinier (1); P Verwaerde (1); J Roncalli (1); T Castillo (1); P Rouet (1); HIGH FAT DIET INDUCES SYNTHESIS OF A NEW CARDIAC SECRETED PROTEIN THAT IS DETECTED IN HDL3
Abstract complet
(1) INSERM U317, Faculté de Médecine, Service de Pharmacologie, TOULOUSE; (2) INSERM U563, CHU Purpan, TOULOUSE;
Poster Lundi 14/04   P68 P Philip-Couderc (1); F Smih (1); A Pathak (1); JM Senard (1); M Galinier (1); P Vervaerde (1); J Roncalli (1); P Massabuau (1); T Castillo (1); P Rouet (1); A NEW CARDIAC HOMEOPROTEIN INDUCED BY NUTRITIONAL OBESITY
Abstract complet
(1) INSERM U317, Faculté de Médecine, Service de Pharmacologie, TOULOUSE;
Poster Lundi 14/04   P69 C Arnaud (1); M Joyeux-Faure (1); D Godin-Ribuot (1); JL Cracowski (1); C Ribuot (1); HEAT STRESS TRIGGERS PROTEIN KINASE C EPSILON TRANSLOCATION AND HSP27 PHOSPHORYLATION
Abstract complet
(1) Laboratoire Hypoxie Physio-Pathologie, Faculté de Pharmacie, GRENOBLE;
Poster Lundi 14/04   P70 C Barel (1); M Belkhiria (2); B Bui-Xuan (3); J Descotes (1); PH Chevalier (4); MC Gagnieu (5); F Arnal (1); P Tsibiribi (1); Q Timour (1); HEMODYNAMIC AND CARDIAC ELECTROPHYSIOLOGICAL EFFECTS OF ROPIVACAINE COMBINED WITH VARIOUS ANTIARRHYTHMIC DRUGS IN THE PIG
Abstract complet
(1) Laboratoire de Pharmacologie Médicale, Université Claude Bernard, LYON; (2) Laboratoire de Pharmacologie, Université de Monastir, MONASTIR, TUNISIE; (3) Département d’Anesthésie Réanimation, Hôpital Edouard Herriot, LYON; (4) Service de Cardiologie, Hôpital Louis Pradel, BRON; (5) Laboratoire de Biochimie, Hôpital Edouard Herriot, LYON;
Poster Lundi 14/04   P71 N Ripoll (1); DJ David (1); MC Colombel (1); M Hascoët (1); M Bourin (1); ANTIDEPRESSANT-LIKE EFFECTS IN VARIOUS MICE STRAINS IN THE TAIL SUSPENSION TEST
Abstract complet
(1) EA 3256 Neurobiologie de l’anxiété et de la dépression, Faculté de Médecine, NANTES;
Poster Lundi 14/04   P72 JM Reymann (1); G Bantsiele (1); M Bourin (2); EFFECT OF MILNACIPRAN COMPARED TO REFERENCE COMPOUNDS ON POST-STROKE EMOTIONAL DISTURBANCES, ASSESSED IN ANIMAL MODELS OF DEPRESSION OR ANXIETY
Abstract complet
(1) EA 3256 Neurobiologie de l’anxiété et de la dépression, Service de Pharmacologie Clinique et Expérimentale, RENNES; (2) EA 3256 Neurobiologie de l’anxiété et de la dépression, Faculté de Médecine, NANTES;
Poster Lundi 14/04   P73 BA Nic Dhonnchadha (1); M Hascoët (1); P Jolliet (1); M Bourin (1); ANXIOLYTIC-LIKE PROPERTIES OF DOI: EVIDENCE FOR A 5-HT2A RECEPTOR MODE OF ACTION
Abstract complet
(1) EA 3256 Neurobiologie de l’anxiété et de la dépression, Faculté de Médecine, NANTES;
Poster Lundi 14/04   P74 M Boulouard (1); V Mauduit (1); V Lelong (1); D Debruyne (2); A Coquerel (2); INTERACTION BETWEEN BUPRENORPHINE AND CLORAZEPATE DIPOTASSIC ON SPONTANEOUS ACTIVITY AND ANXIETY IN THE MOUSE
Abstract complet
(1) Laboratoire de pharmacologie CERMN UPRES EA 2126, Faculté de Pharmacie, Université de Caen, CAEN; (2) Service de Pharmacologie et CEIP Nord Ouest, CHU, CAEN;
Poster Lundi 14/04   P76 V Bertaina-Anglade (1); E Enjuanes (1); C Drieu La Rochelle (1); EFFECTS OF THIOPERAMIDE, AN HISTAMINE H3 ANTAGONIST ON MEMORY PERFORMANCE IN AN OBJECT RECOGNITION TASK IN C57BL6/J MICE
Abstract complet
(1) BIOTRIAL, Department of Preclinical Pharmacology, RENNES;
Poster Lundi 14/04   P77 C Courteix (1); AM Privat (1); T Pélissier (2); A Eschalier (3); J Fialip (1); SPINAL EFFECT OF AGMATINE ON HYPERALGESIA, ALLODYNIA AND MORPHINE-INDUCED ANALGESIA IN DIABETIC RATS
Abstract complet
(1) INSERM 9904 Laboratoire de Pharmacologie Médicale, Faculté de Pharmacie, CLERMONT-FD; (2) Department of pharmacology, Faculty of Medicine University of Chile, SANTIAGO, CHILI; (3) INSERM 9904 Laboratoire de Pharmacologie Médicale, Faculté de Médecine, CLERMONT-FD;
Poster Lundi 14/04   P78 Y Pelloux (1); J Costentin (1); D Duterte-Boucher (1); NOVELTY SEEKING ON THE PLAYGROUND MAZE PREDICTS DRUG CONSUMPTION IN RATS
Abstract complet
(1) UMR CNRS 6036, IFRMP 23, Faculté de Médecine et de Pharmacie, ROUEN;
Poster Lundi 14/04   P79 F Loiseau (1); C Le Bihan (1); M Hamon (1); MH Thiébot (1); LACK OF EFFECTS OF MELATONIN IN TWO ANXIOGENIC CONFLICT PROCEDURES IN RATS
Abstract complet
(1) INSERM U288, Faculté de Médecine Pitié-Salpêtrière, PARIS;
Poster Mardi 15/04   10  P110 MJ Jean-Pastor (1); F Rodor (1); N Nguyen (1); N Prost (1); M Boyer (1); B Gueniot (1); A Paklesa (1); M Valli (1); CALCIUM CHANNEL BLOCKERS AND PHOTOSENSITIVITY
Abstract complet
(1) Centre Régional de Pharmacovigilance, 249, Bd de Sainte-Marguerite, MARSEILLE;
Poster Mardi 15/04   10  P111 E Polard (1); P Latour (2); A Biraben (3); D Bentue-Ferrer (4); O Tribut (4); H Allain (4); DRUG INDUCED ENCEPHALOPATHY IN SIX EPILEPTIC PATIENTS: TOPIRAMATE ? VALPROATE ? OR BOTH ?
Abstract complet
(1) Centre de Pharmacovigilance, Hôpital Pontchaillou, RENNES; (2) Service de Neurologie, Hôpital Cavale Blanche, BREST; (3) Service de Neurologie (Unité Epilepsie), Hôpital Pontchaillou, RENNES; (4) Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine, RENNES;
Poster Mardi 15/04   10  P112 E Polard (1); J Boulliat (2); F Colin (1); D Bentue-Ferrer (3); O Tribut (3); H Allain (3); MYOCLONIC ENCEPHALOPATHY: A DELETERIOUS INTERACTION BETWEEN LEVODOPA AND PROTON PUMP INHIBITORS
Abstract complet
(1) Centre de Pharmacovigilance, Hôpital Pontchaillou, RENNES; (2) Service de Neurologie, Centre Hospitalier Bourg en Bresse, BOURG EN BRESSE; (3) Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine, RENNES;
Poster Mardi 15/04   10  P113 B Lewden (1); T Vial (1); E Elefant (2); A Nelva (3); P Carlier (4); J Descotes (1); Afcrpv (5); LOW-DOSE METHOTREXATE AND PREGNANCY: A FRENCH PROSPECTIVE COLLABORATIVE STUDY
Abstract complet
(1) Centre de Pharmacovigilance, Hôpital Edouard Herriot, LYON; (2) Centre de Renseignements sur les Agents Tératogènes, CHU Saint-Antoine, PARIS; (3) Institut Européen des Génomutations, Rue Edmond Locard, LYON; (4) Centre de Pharmacovigilance, Hôpital Fernand Widal, PARIS; (5) Association Française des Centres Régionaux de Pharmacovigilance, Hôpital St Charles, MONTPELLIER;
Poster Mardi 15/04   10  P114 MA Oscar (1); C Bataillon (2); H Bagheri (1); A Lequellec (3); F Rolland (2); JL Montastruc (1); ADVERSE EFFECTS COULD UPSET THE TREATMENT OF ALCOHOL DEPENDENCE
Abstract complet
(1) Service de Pharmacologie Clinique, Faculté de Médecine-CHU, TOULOUSE; (2) Service d’Alccologie, Hôpitaux de Lannemezan, LANNEMEZAN; (3) Service Pharmacie, Hôpitaux de Lannemezan, LANNEMEZAN;
Poster Mardi 15/04   10  P115 N Bernard (1); T Vial (1); G Bauguil (2); G Chamba (2); J Descotes (1); ADVERSE EFFECTS REPORTED BY COMMUNITY PHARMACY STUDENTS: A 6-MONTH STUDY
Abstract complet
(1) Centre de Pharmacovigilance, Hôpital Edouard Herriot, LYON; (2) Faculté de pharmacie, Département de Pharmacologie, LYON;
Poster Mardi 15/04   10  P116 V Gras-Champel (1); H Masson (1); B Roussel (2); JM Geslin (1); K Masmoud (1); M Andréjak (1); HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) : A PROPOS OF 64 OBSERVATIONS NOTIFIED TO AMIENS PHARMACOVIGILANCE CENTRE (CRPV)
Abstract complet
(1) Pharmacovigilance Centre, CHU Amiens Sud, AMIENS; (2) Haematology laboratory, CHU Amiens Nord, AMIENS;
Poster Mardi 15/04   10  P117 M Masson (1); R Lagnaoui (1); G Miremont-Salamé (1); C Roussillon (1); E Apretna (1); A Laribière (1); F Haramburu (1); DIRECT-TO-PATIENTS INFORMATION FOR DRUGS: ONE-YEAR OBSERVATIONAL STUDY
Abstract complet
(1) Centre Régional de Pharmacovigilance, Département de Pharmacologie, CHU, Université Victor Segalen, BORDEAUX;
Poster Mardi 15/04   10  P118 S Kalimouttou (1); T Lobbedez (2); A Coquerel (1); J Lacotte (1); B Mosquet (1); B Hurault De Ligny (1); APHTOSIS : STUDY IN 28 RENAL TRANSPLANT RECIPIENTS TREATED BY SIROLIMUS
Abstract complet
(1) Pharmacovigilance, CHU, CAEN; (2) Néphrologie, CHU, CAEN;
Poster Mardi 15/04   10  P119 S El Aïdli (1); I Rejeïbi (1); R Daghfous (1); S Trabelsi (1); MH Loueslati (1); M Lakhal (1); C Belkahia (1); SMELL DISORDERS INDUCED BY PYRAZINAMIDE
Abstract complet
(1) Service de recueil et d’analyse des données, Centre National de Pharmacovigilance, TUNIS, TUNISIE;
Poster Mardi 15/04   10  P120 S El Aïdli (1); I Rejeïbi (1); R Daghfous (1); S Trabelsi (1); MH Loueslati (1); M Lakhal (1); C Belkahia (1); ERYTHEMA MULTIFORME INDUCED BY ETHAMBUTOL
Abstract complet
(1) Service de recueil et d’analyse des données, Centre National de Pharmacovigilance, TUNIS, TUNISIE;
Poster Mardi 15/04   10  P121 F Bavoux (1); M Thierry (1); C Vauzelle -Gardier (1); L Chauvelot Moachon (1); POLYTHERAPY WITH HIGH DOSE OF PSYCHOTROPIC DRUGS DURING PREGNANCY,FETAL AND NEONATAL RISKS
Abstract complet
(1) Unité de Pharmacovigilance, Pharmacologie Faculte de Médecine Cochin, PARIS;
Poster Mardi 15/04   10  P122 S El Aïdli (1); K Khiari (2); R Daghfous (1); S Trabelsi (1); T Ben Abdallah (2); MH Loueslati (1); M Ben Maïz (2); C Belkahia (1); A CASE OF SEVER LOCAL CUTANEOUS REACTIONS TO INSULIN : HUMAN INSULIN DESENSITIZATION RESULT
Abstract complet
(1) Service de recueil et d’analyse des données, Centre National de Pharmacovigilance, TUNIS, TUNISIE; (2) Service de Médecine Interne, Hôpital Charles Nicolle, TUNIS, TUNISIE;
Poster Mardi 15/04   10  P123 C Bousquet (1); A Lillo-Le Louët (1); C Le Beller (1); G Lagier (2); PRINCIPLES OF SEMANTIC NETWORKS FOR AUTOMATED SIGNAL DETECTION IN PHARMACOVIGILANCE
Abstract complet
(1) CRPV d’HEGP, Hôpital Européen Georges Pompidou, PARIS; (2) CRPV Fernand Widal, Hôpital Fernand Widal, PARIS;
Poster Mardi 15/04   10  P124 L Lagarce (1); JM Thoulon (2); H Plauchu (3); P Lainé-Cessac (1); E Robert (4); CALCIUM CHANNEL BLOCKERS IN PREGNANCY, THE EXPERIENCE OF THE FRENCH PHARMACOVIGILANCE CENTRES
Abstract complet
(1) CRPV, Laboratoire de pharmacologie CHU, ANGERS; (2) Gynécologie obstétrique, hopital Edouard Herriot pavillon K, LYON; (3) Génétique, Hôtel-Dieu, LYON; (4) IEG, Institut Européen des génomutations, LYON;
Poster Mardi 15/04   10  P125 K Martin (1); S Lawson-Ayayi (2); G Miremont-Salamé (1); AM Formaggio (3); D Lacoste (3); M Dupon (3); T Schaverberke (4); P Mercié (3); JM Ragnaud (3); F Haramburu (1); F Dabis (2); SYMPTOMATIC OSTEOPENIA AND OSTEOPOROSIS IN HIV-INFECTED PATIENTS, AQUITAINE COHORT 1999 – 2002
Abstract complet
(1) Centre Régional de Pharmacovigilance, Département de Pharmacologie, Université Victor Segalen, CHU, BORDEAUX; (2) INSERM U330, Université Victor Segalen Bordeaux 2, BORDEAUX; (3) Centre d’Information et de Soins sur l’Immunodéficience Humaine, CHU, BORDEAUX; (4) Service de Rhumatologie, CHU, BORDEAUX;
Poster Mardi 15/04   10  P126 F Bentaberry (1); K Martin (2); C Dumoulin (1); J Dehais (1); F Haramburu (2); F Liefferman (3); T Schaeverbeke (1); PERIPHERAL NEUROPATHY DURING LEFLUNOMIDE TREATMENT: A REPORT OF 5 CASES
Abstract complet
(1) Service de Rhumatologie, CHU, BORDEAUX; (2) Centre Régional de Pharmacovigilance, Département de Pharmacologie, Université Victor Segalen Bordeaux 2, CHU, BORDEAUX; (3) Service de Médecine Interne, CH, DAX;
Poster Mardi 15/04   10  P127 S Ginisty (1); N Grené (2); P Eftekhari (1); M Rajad (1); G Lagier (1); DEPRESSION IN HIV-POSITIVE PATIENTS TREATED WITH EFAVIRENZ : 87 CASES RECORDED IN FRENCH PHARMACOVIGILANCE DATABASE (FROM 13/09/1999 TO 31/01/2002)
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Fernand Widal, PARIS; (2) Agence française de sécurité sanitaire des produits de santé, Bld Anatole France, ST DENIS;
Poster Mardi 15/04   10  P128 L Laforest (1); R Harf (2); F Clouet (3); C Ségala (4); D Poizeau (4); G Pietri (1); Y Pacheco (2); E Van Ganse (1); RELATIONSHIP BETWEEN RAGWEED POLLINATION COUNTS AND DELIVERY OF ANTI ALLERGIC MEDICATION
Abstract complet
(1) Unité de Pharmacoépidémiologie, Centre Hospitalier Universitaire Lyon Sud, PIERRE-BENITE; (2) Service de pneumologie, Centre Hospitalier Universitaire Lyon Sud, PIERRE-BENITE; (3) Service Médical, Caisse Primaire d’Assurance Maladie de Lyon, LYON; (4) SEPIA Santé, MELRAND;
Poster Mardi 15/04   10  P129 F Depont (1); A Abouelfath (1); E Hunsche (2); I Addra (1); T Diatta (1); A Grelaud (1); N Moore (1); THERAPEUTIC MANAGEMENT OF CHRONIC LOW BACK PAIN IN FRANCE
Abstract complet
(1) Département de Pharmacologie, Université Victor Segalen Bordeaux 2, BORDEAUX; (2) Merck & Co., Whitehouse Station, NJ, USA;
Poster Mardi 15/04   10  P130 I Lacroix (1); S Saivin (2); M Lapeyre-Mestre (1); JL Montastruc (1); C Damase-Michel (1); EFFECTS OF MATERNAL PSYCHOTROPIC USE OR ABUSE IN NEWBORNS : PRELIMINARY RESULTS OF THE PHARMACOEPIDEMIOLOGIC STUDY NENUPHAR
Abstract complet
(1) Service de Pharmacologie Clinique, Faculté de Médecine, TOULOUSE; (2) Laboratoire de toxicologie clinique, CHU, TOULOUSE;
Poster Mardi 15/04   10  P131 N Lechevallier (1); A Fourrier (1); C Berr (2); INCIDENCE OF BENZODIAZEPINE USE AND FACTORS ASSOCIATED WITH SUBSEQUENT USE IN THE ELDERLY: THE EVA STUDY
Abstract complet
(1) Département de Pharmacologie, Université Victor Segalen Bordeaux 2, BORDEAUX; (2) INSERM EMI-9930, Hôpital de la Colombière, MONTPELLIER;
Poster Mardi 15/04   10  P132 A Fourrier (1); S De Bailliencourt (2); P Latry (2); C Peter (2); N Moore (1); B Bégaud (1); CHARACTERISTICS OF CELECOXIB PRESCRIPTIONS IN THE AQUITAINE REGION: DATA FROM THE REGIONAL DATABASE OF THE SECURITE SOCIALE
Abstract complet
(1) Pharmacologie Clinique, Université Victor Segalen Bordeaux 2, BORDEAUX; (2) Direction Régionale Service médical assurance maladie Aquitaine, Avenue de la Jallère, BORDEAUX;
Poster Mardi 15/04   10  P133 T Simon (1); A Chatelin (2); M Thuault (2); H Kolsky (3); P Jaillon (1); EPIFLEC : PHARMACO-EPIDEMIOLOGIC SURVEY OF FLECAINIDE TREATMENT IN A COHORT OF PATIENTS WITH ATRIAL FIBRILLATION
Abstract complet
(1) Service de Pharmacologie, Hôpital Saint-Antoine, AP-HP – UP6, PARIS; (2) MEDICAWEB, 67 rue Vergniaud, PARIS; (3) 3M SANTE, Bd de l’Oise, CERGY PONTOISE;
Poster Mardi 15/04   10  P134 N Lechevallier (1); A Fourrier (1); C Berr (2); PREVALENCE AND CHARACTERISTICS OF BENZODIAZEPINE USE IN THE ELDERLY: THE EVA STUDY
Abstract complet
(1) Département de Pharmacologie, Université Victor Segalen Bordeaux 2, BORDEAUX; (2) INSERM EMI-9930, Hôpital de la Colombière, MONTPELLIER;
Poster Mardi 15/04   10  P135 S Rambelomanana (1); E Giauque (1); R Lagnaoui (1); A Abouelfath (1); P Brochard (2); I Buisson Valles (2); P Gabinski (2); B Bioulac (3); P Philip (3); N Moore (1); THE EFFECTS OF MEDICATION AND SLEEP ON WORKPLACE ACCIDENTS
Abstract complet
(1) Département de Pharmacologie, Université Victor Segalen Bordeaux 2, BORDEAUX; (2) Service de Médecine du travail, CHU de Bordeaux, BORDEAUX; (3) Clinique du sommeil, CHU de Bordeaux, BORDEAUX;
Poster Mardi 15/04   10  P136 M Lapeyre-Mestre (1); M Pin (1); PEDIATRIC COUNSELLING IN COMMUNITY PHARMACIES : KNOWLEDGE OF PHARMACISTS AND PHARMACY TECHNICIANS ABOUT DRUG UTILISATION IN CHILDREN
Abstract complet
(1) Service de Pharmacologie Clinique, Unité de Pharmacoépidémiologie, Faculté de Médecine, TOULOUSE;
Poster Mardi 15/04   10  P137 E Polard (1); S Belliard (2); D Bentue-Ferrer (3); P Le Cavorzin (4); R Duclos (1); AG Le Guen (1); MALAISE AND LOSS OF CONSCIOUSNESS IN DEMENTED PATIENTS TREATED BY ACETYLCHOLINESTERASE INHIBITORS
Abstract complet
(1) Centre de Pharmacovigilance, Hôpital Pontchaillou, RENNES; (2) Service de Neurologie, Hôpital Pontchaillou, RENNES; (3) Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine, RENNES; (4) Centre de Rééducation Fonctionnelle, Rennes, RENNES;
Poster Mardi 15/04   10  P138 T Ngoundo (1); M Niezborala (2); JL Montastruc (1); M Lapeyre-Mestre (1); PSYCHOACTIVE DRUG CONSUMPTION IN WORKERS AND PERFORMANCE AT WORK
Abstract complet
(1) Unité de Pharmacoépidémiologie, Service de Pharmacologie Clinique, Faculté de Médecine, TOULOUSE; (2) Service Médical Inter-Entreprises, SMIT de Toulouse, TOULOUSE;
Poster Mardi 15/04   10  P139 P Maison (1); F Fric (1); P Cunin (2); N Elie (3); F Hemery (4); L Hittinger (5); I Masquin-Mavier (1); DRUG PRESCRIPTION AND REHOSPITALISATION RISK IN CHRONIC HEART FAILURE. LONGITUDINAL PHARMACOEPIDEMIOLOGICAL STUDY
Abstract complet
(1) Service Pharmacologie Clinique, Hopital Henri Mondor, CRETEIL; (2) Unité de Recherche Clinique, Université Paris XII, CRETEIL; (3) CPAM 94, Val de Marne, CRETEIL; (4) Departement Information Médicale, Hopital Henri Mondor, CRETEIL; (5) Fédération Cardiologie, Hopital Henri Mondor, CRETEIL;
Poster Mardi 15/04   10  P140 R Serreau (1); MF Le Heuzey (2); A Gilbert (1); YI Dubois (1); MC Mouren (2); E Jacqz-Aigrain (1); PSYCHOTROPIC MEDICATION IN CHILDREN : A FRENCH PROSPECTIVE SURVEY
Abstract complet
(1) Pharmacology Unit, Robert Debré Hospital, PARIS; (2) Psychopathology Unit, Robert Debré Hospital, PARIS;
Poster Mardi 15/04   11  P141 G Naelten (1); B Chapuis (1); M Lo (1); J Sassard (1); LONG TERM EFFECTS OF RENIN-ANGIOTENSIN SYSTEM BLOCKADE IN GENETICALLY HYPERTENSIVE RATS OF THE LYON STRAIN (LH)
Abstract complet
(1) CNRS UMR 5014, Faculté de Pharmacie, LYON;
Poster Mardi 15/04   11  P142 V Marque (1); M Grima (2); P Kieffer (1); C Capdeville-Atkinson (1); J Atkinson (1); I Lartaud-Idjouadiene (1); WITHDRAWAL REVEALS LACK OF EFFECT OF PROLONGED ANTIHYPERTENSIVE TREATMENT ON INTRINSIC AORTIC WALL STIFFNESS IN SENESCENT SHR
Abstract complet
(1) EA, 3448 / Faculté de Pharmacie, NANCY; (2) CNRS 0589, Faculté de Médecine, 11 rue Humann, STRASBOURG;
Poster Mardi 15/04   11  P143 JL Cracowski (1); JP Baguet (2); O Ormezzano (2); J Bessard (1); F Stanke-Labesque (1); G Bessard (1); JM Mallion (2); LIPID PEROXIDATION IS NOT INCREASED IN PATIENTS WITH UNTREATED MILD TO MODERATE HYPERTENSION
Abstract complet
(1) Laboratoire de Pharmacologie, Faculté de Médecine, GRENOBLE; (2) Fédération des maladies cardio-vasculaires, CHU Grenoble, GRENOBLE;
Poster Mardi 15/04   11  P144 I Signolet (1); P Bousquet (1); L Monassier (1); EFFECTS OF THE CENTRALLY ACTING SYMPATHOINHIBITOR, RILMENIDINE, IN 1K1C GOLDBLATT HYPERTENSIVE RABBITS
Abstract complet
(1) Laboratoire de Neurobiologie et Pharmacologie Cardiovasculaire, Faculté de Médecine, STRASBOURG;
Poster Mardi 15/04   11  P145 P Sassano (1); C Yau (1); E Ghannad (1); H Karam (1); B Fiquet (1); PROPULSION STUDY : TO ASSESS THE TOLERABILITY OF VALSARTAN (80 THEN 160 MG) IN MONOTHERAPY OVER 8 WEEKS IN HYPERTENSIVE PATIENTS AT HIGH CARDIOVASCULAR RISK
Abstract complet
(1) Novartis Pharma SAS, 2-4 rue Lionel Terray, RUEIL MALMAISON;
Poster Mardi 15/04   11  P146 H Greney (1); D Urosevic (1); S Schann (1); L Dupuy (1); JD Ehrhardt (1); P Bousquet (1); A NEW RADIOACTIVE TOOL FOR INVESTIGATION OF I1 IMIDAZOLINE RECEPTORS
Abstract complet
(1) Laboratoire de Neurobiologie et Pharmacologie Cardiovasculaire, Faculté de Médecine, STRASBOURG;
Poster Mardi 15/04   11  P147 H Masson (1); J Varagic (2); D Susic (2); E Frohlich (2); M Andréjak (1); M Slama (1); LEFT VENTRICULAR DIASTOLIC FUNCTION : ASSESSMENT IN SPONTANEOUS HYPERTENSIVE RAT (SHR)
Abstract complet
(1) Cardiovascular physiopathology Lab, Faculté de médecine UPJV, AMIENS; (2) Ochsner Clinic Foundation, NEW ORLEANS, USA;
Poster Mardi 15/04   11  P148 F Gueyffier (1); F Boutitie (2); JP Boissel (1); WHICH ARE THE RELEVANT QUESTIONS BEHIND THE RELATION BETWEEN A CONTINUOUS BIOMARKER AND A CLINICAL OUTCOME ? EXAMPLE OF BLOOD PRESSURE
Abstract complet
(1) Service de Pharmacologie Clinique, Faculté RTH Laennec, LYON; (2) Service de Biostatistiques, Hospices Civils de Lyon, LYON;
Poster Mardi 15/04   12  P149 T Simon (1); M Mary-Krause (2); C Funck-Brentano (1); PH Lechat (3); P Jaillon (1); BISOPROLOL DOSE-RESPONSE RELATIONSHIP IN PATIENTS WITH CONGESTIVE HEART FAILURE
Abstract complet
(1) Service de Pharmacologie, Hôpital Saint-Antoine, AP-HP – UP6, PARIS; (2) INSERM EMI-0214, Hôpital Pitié-Salpétrière, PARIS; (3) Service de Pharmacologie, Hôpital Pitié-Salpétrière, PARIS;
Poster Mardi 15/04   12  P150 P Nony (1); E Amsallem (1); C Kasparian (1); G Haddour (1); JP Boissel (1); , For The Cardiodas Study Group (1); EVALUATION OF THE EFFECT OF PHOSPHODIESTERASE III INHIBITORS IN CHRONIC HEART FAILURE PATIENTS : AN UPDATED META-ANALYSIS
Abstract complet
(1) EA 643, Hôpital Cardiologique, LYON;
Poster Mardi 15/04   12  P151 N Mougenot (1); O Mediani (1); R Bos (1); F Brouri (1); P Lechat (1); CAPTOPRIL-FUROSEMIDE EFFECTS ON SURVIVAL ON THE EXPERIMENTAL MODEL OF HEART FAILURE IN THE RAT INDUCED BY MYOCARDIAL INFARCTION
Abstract complet
(1) IFR 14 Pharmacology Department, Pitié Salpêtrière Hospital, PARIS;
Poster Mardi 15/04   12  P152 L Chauvelot-Moachon (1); L Fouqueray (2); C Vauzelle (1); F Bavoux (1); DOES PHARMACOLOGICAL STIMULATION OF RETINOIC ACID RECEPTORS AND RETINOID X RECEPTORS EXPOSE TO A RISK OF CARDIAC TOXICITY, AT TERM?
Abstract complet
(1) Pharmacovigilance, Faculté de Médecine et Hôpital Cochin, PARIS; (2) Cardiologie, Soisy sur Seine, SOISY;
Poster Mardi 15/04   12  P153 P Mulder (1); V Mellin (1); A Jeng (1); JP Henry (1); C Thuillez (1); ADDTIVE EFFECTS OF TRIPLE ACE, ECE AND NEP INHIBITION ON HEMODYNAMICS, CARDIAC REMODELING AND FUNCTION IN RATS WITH CHRONIC HEART FAILURE
Abstract complet
(1) INSERM E9920, Faculté de Médecine et de Pharmacie, ROUEN;
Poster Mardi 15/04   13  P154 C Arnaud (1); JL Cracowski (1); A Hakim (1); T Durand (2); A Guy (2); D Godin-Ribuot (1); G Bessard (1); C Ribuot (1); ISOPROSTANES 15-F2T-ISOP AND 5-F2T-ISOP ARE NOT TRIGGERS OF MYOCARDIAL PRECONDITIONING
Abstract complet
(1) Laboratoire de Pharmacologie, Faculté de Médecine, GRENOBLE; (2) Laboratoire de Chimie Biomoléculaire et Interactions Biologiques, UMR CNRS 5074, Faculté de Pharmacie de Montpellier, MONTPELLIER;
Poster Mardi 15/04   13  P155 K Aouam (1); R Tissier (1); R Souktani (1); A Berdeaux (1); B Ghaleh (1); MEASUREMENT OF POST-ISCHEMIC SYSTOLIC FUNCTION IN THE REPERFUSED HEART IN CONSCIOUS RABBITS: EFFECT OF PRECONDITIONING
Abstract complet
(1) Laboratoire de Pharmacologie et INSERM E 00.01, Faculté de Médecine Paris Sud, LE KREMLIN-BICETRE;
Poster Mardi 15/04   13  P156 T Damy (1); A Bouzamondo (1); G Montalescot (2); P Lechat (1); SUPERIOR EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN VERSUS UNFRACTIONNATED HEPARIN IN ACUTE CORONARY SYNDROMES WITHOUT ST ELEVATION
Abstract complet
(1) Service de Pharmacologie, Hôpital Pitié-Salpêtrière, PARIS; (2) Service de Cardiologie, Hôpital Pitié-Salpêtrière, PARIS;
Poster Mardi 15/04   13  P157 C Arnaud (1); M Joyeux (1); D Godin-Ribuot (1); JL Cracowski (1); C Ribuot (1); COX-2: AN IN VIVO EVIDENCE OF ITS PARTICIPATION TO HEAT STRESS-INDUCED MYOCARDIAL PRECONDITIONING
Abstract complet
(1) Laboratoire Hypoxie Physio-Pathologie, Faculté de Pharmacie, GRENOBLE;
Poster Mardi 15/04   14  P158 F Chenu (1); N Ripoll (1); DJ David (1); M Hascoët (1); M Bourin (1); AN APPROPRIATE STRATEGY FOR SCREENING ANTIDEPRESSANT DRUGS USING THE MOUSE FORCED SWIMMING TEST AND THE TAIL SUSPENSION TEST
Abstract complet
(1) EA 3256 Neurobiologie de l’anxiété et de la dépression, Faculté de Médecine, NANTES;
Poster Mardi 15/04   14  P159 D Tallet (1); P Del Soldato (2); M Bolla (2); N Oudart (1); NCX 950 (NO-SALBUTAMOL) SIGNIFICANTLY INHIBITS METHACHOLINE INDUCED BRONCHOCONSTRICTION AND REDUCES TACHYPHYLAXIS
Abstract complet
(1) Laboratoire de Pharmacologie, Faculté de Pharmacie, LIMOGES; (2) Nicox SA, Route des Dolines, SOPHIA ANTIPOLIS;
Poster Mardi 15/04   14  P160 N Picard (1); D Ratanasavanh (2); Y Le Meur (3); A Rousseau (1); P Marquet (1); IN VITRO AND IN VIVO STUDY OF MYCOPHENOLIC ACID PHASE II METABOLISM
Abstract complet
(1) Service de Pharmacologie et Toxicologie, CHU, LIMOGES; (2) Laboratoire de Pharmacologie, CHU Brest, BREST; (3) Service de néphrologie, CHU, LIMOGES;
Poster Mardi 15/04   14  P161 M Molimard (1); C Raherison (2); S Lignot (1); A Abouelfath (1); F Depont (1); N Moore (1); REAL-LIFE HANDLING OF INHALER DEVICES IN 3811 PATIENTS
Abstract complet
(1) Département de Pharmacologie, Université Victor Segalen Bordeaux 2, BORDEAUX; (2) Service des Maladies Respiratoires, Hôpital Haut Lévèque, PESSAC;
Poster Mardi 15/04   14  P162 G Ravel (1); M Christ (1); F Horand (1); J Descotes (2); EFFECT OF TWO PEDIATRIC VACCINES ON INSULIN-DEPENDENT DIABETES MELLITUS (IDDM) IN FEMALE NOD MICE
Abstract complet
(1) MDS Pharma Services, Les Oncins, SAINT-GERMAIN-SUR-L’ARBRESLE; (2) Poison Center, E. Herriot Hospital, LYON;
Poster Mardi 15/04   14  P163 M Mallem (1); V Bucas (1); F Gautier (1); M Gogny (1); J Desfontis (1); BETA3 AND ATYPICAL BETA-ADRENOCEPTORS IN HYPERTENSION
Abstract complet
(1) UPSP5304, Ecole Vétérinaire, NANTES;
Poster Mardi 15/04   14  P164 PA Risse (1); E Naline (1); G Huchon (2); C Advenier (1); N Roche (2); ROLE OF PAR-2 IN THE REGULATION OF AIRWAY SMOOTH MUSCLE (SM) TONE
Abstract complet
(1) UPRES EA220, UFR Biomédicale des Saints Pères, PARIS; (2) Service de Pneumologie et de Réanimation, Hôpital de l’Hôtel Dieu, PARIS;
Poster Mardi 15/04   14  P165 A Appert-Collin (1); A Lebon (1); P Poindron (1); JP Ges (1); CELL CYCLE REGULATORS IN MOTONEURONAL DEATH EVOKED BY NEUROTROPHIC FACTOR DEPRIVATION
Abstract complet
(1) LPCCNM, Faculté de pharmacie, ILLKIRCH;
Poster Mardi 15/04   14  P166 C Pascarel (1); A- El Amrani (1); K Viaud (1); R Dalonneau (1); C Champeroux (1); S Richard (1); HERG TRANSFECTED HEK-293 CELLS: A PHARMACOLOGICAL TOOL FOR DRUG ASSESSMENT OF QT INTERVAL PROLONGATION
Abstract complet
(1) CERB, Chemin de Montifault, BAUGY;
Poster Mardi 15/04   14  P167 M Bastide (1); O Pétrault (2); L Gruand (2); M Laprais (2); S Stolc (3); R Bordet (2); PROTECTIVE EFFECTS OF STOBADINE, AN ANTIOXIDANT AGENT, ON NEURONAL AND VASCULAR ALTERATIONS INDUCED BY ISCHEMIA/REPERFUSION (I/R) ON RAT
Abstract complet
(1) IUT A, Université de Lille 1, VILLENEUVE D’ASCQ; (2) Laboratoire de Pharmacologie, Faculté de Médecine de Lille 2, LILLE; (3) Institut de Pharmacologie Expérimentale, Académie Slovaque des Sciences, BRATISLAVA, SLOVAQUIE;
Poster Mercredi 16/04   15  P168 C Verstuyft (1); M Schwab (2); E Schaeffeler (2); R Kerb (3); U Brinkmann (3); P Jaillon (1); C Funck-Brentano (1); L Becquemont (1); DIGOXIN PHARMACOKINETICS AND MDR1 GENETIC POLYMORPHISMS
Abstract complet
(1) Pharmacologie, Faculté de médecine Saint-Antoine, PARIS; (2) Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Robert Bosch foundation, STUTTGART, ALLEMAGNE; (3) Epidauros Biotechnologie, Epidauros Biotechnologie, BERNRIED, ALLEMAGNE;
Poster Mercredi 16/04   15  P169 S Morin (1); MA Loriot (2); HK Thijssen (3); A Robert (4); S Strabach (5); C Verstuyft (1); L Dubert (1); C Funck-Brentano (5); P Jaillon (1); PH Beaune (2); L Becquemont (1); VARIATIONS OF INR AND FACTOR VII ARE LINKED TO CYTOCHROME P450 2C9 GENOTYPE
Abstract complet
(1) Service de Pharmacologie, Faculté de médecine Saint-Antoine, PARIS; (2) INSERM U 490, Université Paris V, PARIS; (3) Service de Pharmacologie, Université de Maastricht, MAASTRICHT, PAYS-BAS; (4) Service d’hémostase, CHU Saint-Antoine, PARIS; (5) Centre d’investigation clinique, CHU Saint-Antoine, PARIS;
Poster Mercredi 16/04   15  P170 T Damy (1); F Pousset (2); H Caplain (3); JS Hulot (1); PH Lechat (1); PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN METOPROLOL AND DRONEDARONE IN HEALTHY SUBJECTS
Abstract complet
(1) Service de Pharmacologie, Hôpital Pitié-Salpétrière, PARIS; (2) Service de Cardiologie, Hôpital Pitié-Salpétrière, PARIS; (3) Aster Clinical Research Center, 3-5 rue Eugène Millon, PARIS;
Poster Mercredi 16/04   15  P171 D Zhang (1); C Ganière-Monteil (2); Y Médard (1); M Bourin (2); E Jacqz-Aigrain (1); PHENOTYPE AND GENOTYPE FOR THIOPURINE METHYLTRANSFERASE ACTIVITY IN THE FRENCH CAUCASIAN POPULATION: IMPACT OF AGE
Abstract complet
(1) Pharmacologie Pédiatrique – Pharmacogénétique, Hôpital Robert Debré, PARIS; (2) Pharmacologie, Hôpital Hôtel-Dieu, NANTES;
Poster Mercredi 16/04   15  P172 M Fakhoury (1); R Serreau (1); Y Medard (1); AL Delezoide (2); E Jacqz-Aigrain (1); REAL TIME QUANTITATIVE RT-PCR OF CYP3A IN PLACENTA
Abstract complet
(1) Pharmacology Unit, Robert Debré Hospital, PARIS; (2) Foetopathology unit, Robert Debré Hospital, PARIS;
Poster Mercredi 16/04   15  P173 JM Poirier (1); O Zouai (1); JL Meynard (2); K Lacombe (2); PM Girard (2); P Jaillon (1); LACK OF EFFECT OF GENDER, AGE, WEIGHT AND BODY MASS INDEX ON TROUGH LOPINAVIR PLASMA CONCENTRATIONS IN HIV-EXPERIENCED PATIENTS TREATED WITH KALETRA
Abstract complet
(1) Department of pharmacology, Saint-Antoine University Hospital, PARIS; (2) Department of Infectious Diseases, Saint-Antoine Hospital, PARIS;
Poster Mercredi 16/04   15  P174 S Laporte (1); B Tranchand (2); A Viallon (3); M Ollagnier (4); M Cucherat (5); C Guy (4); H Décousus (1); P Mismetti (1); POOLING OF INDIVIDUAL TOXICOKINETIC CASE REPORTS USING A POPULATION APPROACH MODEL
Abstract complet
(1) Unité de Pharmacologie Clinique, EA3065, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (2) Centre Léon Bérard, Rue Laënnec, LYON; (3) Service d’Accueil des Urgences, EA3065, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (4) Unité de Pharmacologie et Toxicologie, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (5) EA 643 Faculté RTH Laennec, Service de Biostatistiques, CHU Lyon, LYON;
Poster Mercredi 16/04   15  P175 F Stanke-Labesque (1); S Larrat (1); G Bessard (1); JP Zarski (2); C Souvignet (2); RIBAVIRIN QUANTIFICATION FOR THERAPEUTIC DRUG MONITORING DURING CHRONIC HEPATITIS C COMBINATION TREATMENT
Abstract complet
(1) Laboratoire de Pharmacologie, CHU Grenoble, GRENOBLE; (2) Département d’hépato-gastroentérologie, CHU Grenoble, GRENOBLE;
Poster Mercredi 16/04   15  P176 N Simon (1); G Slepchenko (2); O Pérus (2); JC Levron (3); M Raucoules-Aimé (2); B Bruguerolle (1); POPULATION PHARMACOKINETICS OF SUFENTANIL IN OBESE PATIENTS
Abstract complet
(1) Laboratoire de Pharmacologie médicale et clinique, Faculté de médecine, MARSEILLE; (2) Département d’anesthésie-réanimation, Hôpital l’Archet 2, NICE; (3) Laboratoire Janssen Cilag, Janssen Research Fondation, VAL DE REUIL;
Poster Mercredi 16/04   15  P177 N Simon (1); F Lacroix (2); E Deturmeny (1); O Paut (2); J Camboulives (2); B Bruguerolle (1); COMPARATIVE PHARMACOKINETICS OF 0.2 VS 0.375 % ROPIVACAINE DURING FASCIA ILIACA COMPARTMENT BLOCK IN CHILDREN
Abstract complet
(1) Laboratoire Pharmacologie médicale et clinique, Faculté de médecine, MARSEILLE; (2) Departement d’anesthésie Réanimation Pédiatrique, CHU Timone, MARSEILLE;
Poster Mercredi 16/04   15  P178 P Nony (1); JP Boissel (1); PREDICTING DRUG FORGIVENESS: A STANDARDISED GRAPHICAL APPROACH
Abstract complet
(1) EA 643, Hôpital Cardiologique, LYON;
Poster Mercredi 16/04   15  P179 E Dailly (1); M Pannier (2); P Jolliet (1); M Bourin (1); POPULATION PHARMACOKINETICS OF CEFTAZIDIME IN BURN PATIENTS
Abstract complet
(1) Laboratoire de Pharmacologie, Hôtel Dieu, NANTES; (2) Service des Brûlés, Hôtel Dieu, NANTES;
Poster Mercredi 16/04   15  P180 S Payen (1); R Serreau (2); A Munck (3); Y Aujard (4); Y Aigrain (5); F Bressolle (1); E Jacqz-Aigrain (2); POPULATION PHARMACOKINETICS OF CIPROFLOXACIN IN PEDIATRIC AND ADOLESCENT PATIENTS WITH ACUTE INFECTIONS
Abstract complet
(1) Clinical Pharmacokinetic Laboratory, Faculty of Pharmacy, MONTPELLIER; (2) Paediatric Pharmacology and Pharmacogenetics, Robert Debré Hospital, PARIS; (3) Gastro-Enterology, Robert Debré Hospital, PARIS; (4) Neonatologie, Robert Debré Hospital, PARIS; (5) Paediatric Surgery, Robert Debré Hospital, PARIS;
Poster Mercredi 16/04   15  P181 C Verstuyft (1); F Marcellin (2); L Morand-Joubert (3); O Launay (4); G Peytavin (5); L Gerard (2); L Becquemont (6); JP Aboulker (2); For The Anrs 081 (7); IMPACT OF MDR1 (C3435T) GENETIC POLYMORPHISM IN PATIENTS NAÏVE TREATED WITH HAART INCLUDING INDINAVIR (IDV)
Abstract complet
(1) Pharmacology Department, Faculty of medecine, PARIS; (2) SC 10, Villejuif, VILLEJUIF; (3) Virology Department, Saint-Antoine Hospital, PARIS; (4) Infectious Disease Department, Bichat-Claude Bernard, PARIS; (5) Pharmacy Department, Bichat-Claude Bernard, PARIS; (6) Pharmacology Department, Saint-Antoine Hospital, PARIS; (7) ANRS, PARIS;
Poster Mercredi 16/04   15  P182 X Zhang (1); V Favier (2); JM Lang (3); J Reynes (4); D Rey (3); R Rouzier-Panis (5); M Gerber (2); E Gaudeul-Ehrhart (2); P Desche (2); I Patel (1); PHARMACOKINETICS OF HIV FUSION INHIBITOR T-20 (FUZEON) AFTER BOTH INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) ADMINISTRATION TO HIV-1 INFECTED PATIENTS
Abstract complet
(1) Clinical pharmacology dpt, Hoffmann-La ROCHE Inc., NUTLEY, USA; (2) Institut de Pharmacologie Clinique ROCHE, Hôpital Civil de Strasbourg, STRASBOURG; (3) Antenne d’Immuno-Onco-Hematologie, Hôpital Civil de Strasbourg, STRASBOURG; (4) Service des Maladies Infectueuses et Tropicales, Hôpital Gui de Chauliac, MONTPELLIER; (5) Centre CAP, Clinique Rech, MONTPELLIER;
Poster Mercredi 16/04   15  P183 E Caudron (1); V Jullien (1); C Amrein (2); R Guillemain (2); P Chevallier (2); C Le Beller (1); A Lillo-Le Louet (1); EM Billaud (1); TACROLIMUS THERAPEUTIC DRUG MONITORING (TDM) IN THE MANAGEMENT OF DRUG INTERACTION WITH VORICONAZOLE IN PULMONARY TRANSPLANTATION
Abstract complet
(1) Pharmacologie Toxicologie, HEGP, PARIS; (2) Chirurgie Cardio Vasculaire, HEGP, PARIS;
Poster Mercredi 16/04   15  P184 O Tribut (1); C Camus (2); C Arvieux (3); H Allain (1); D Bentué-Ferrer (1); TACROLIMUS AND PROTEASE INHIBITORS INTERACTION IN PATIENTS WITH LIVER TRANSPLANTATION
Abstract complet
(1) Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine, RENNES; (2) Service de Réanimation Médicale, Hôpital Pontchaillou, RENNES; (3) Service des Maladies Infectieuses, Hôpital Pontchaillou, RENNES;
Poster Mercredi 16/04   15  P185 N Ferrari (1); S Brique (1); P Odou (2); L Kroumova (1); C Lamotte (1); J Wiart (3); P Devos (4); M Lhermitte (3); C Libersa (1); NIFEDIPINE AND GRAPEFRUIT JUICE: FACT OR FICTION ?
Abstract complet
(1) CIC Lille, CHRU LILLE, LILLE; (2) Département de biopharmacie et de pharmacie clinique, Faculté de Pharmacie, LILLE; (3) Laboratoire de biochimie et de biologie moléculaire, CHRU LILLE, LILLE; (4) D.I.M., CHRU LILLE, LILLE;
Poster Mercredi 16/04   15  P186 B Guillet (1); B Bordas (1); R Purgus (2); B Dussol (2); A Durand (1); Y Berland (2); P Pisano (1); PHARMACOKINETICS OF MYCOPHÉNOLIC ACID (MPA) TOTAL AND FREE IN RENAL TRANSPLANT PATIENTS WITH CHRONIC GRAFT DYSFUNCTION
Abstract complet
(1) Fédération de Pharmacologie, CHU Timone, 254 rue St Pierre, MARSEILLE; (2) Service de Néphrologie, CHU Conception, 170 bd Baille, MARSEILLE;
Poster Mercredi 16/04   15  P187 Y Hijazi (1); R Boulieu (2); CONTRIBUTION OF CYP3A4, CYP2B6, AND CYP2C9 ISOFORMS TO N-DEMETHYLATION OF KETAMINE IN HUMAN LIVER MICROSOMES
Abstract complet
(1) PDMP, Hoffmann-La Roche, BASEL, SWITZERLAND; (2) Laboratoire de Pharmacocinétique Clinique, Université de Lyon 1, LYON;
Poster Mercredi 16/04   16  P188 P Meshaka (1); N Mouchet (2); C Gaillez (1); S Sans (3); D Muzard (3); P Pinton (1); TREATMENT OF SEVERE SEPSIS WITH 2 ORGAN FAILURES – TEMPORARY AUTHORIZATION OF USE (TAU) OF XIGRIS IN ADULTS AND CHILDREN
Abstract complet
(1) Unité Thérapeutique Cardiologie, Infectiologie et Réanimation, Lilly France, SURESNES; (2) Département des Affaires Réglementaires, Lilly France, SURESNES; (3) Département de Pharmacovigilance, Lilly France, SURESNES;
Poster Mercredi 16/04   16  P189 K Lacut (1); E Oger (1); G Le Gal (1); F Couturaud (1); S Louis (2); C Leroyer (1); D Mottier (1); STATIN USE IS ASSOCIATED WITH A REDUCED RISK FOR VENOUS THROMBOEMBOLISM
Abstract complet
(1) Département de Médecine Interne et Pneumologie, CHU Cavale Blanche, BREST; (2) Unité d’Echo-Doppler, CHU Cavale Blanche, BREST;
Poster Mercredi 16/04   16  P190 S Dias (1); M Cucherat (1); E Amsallem (1); JP Boissel (1); ACCEPTABILITY BY GPS OF A NEW APPROACH OF KNOWLEDGE TRANSFER IN THERAPEUTICS
Abstract complet
(1) EA 643, Faculté de médecine RTH Laennec, LYON;
Poster Mercredi 16/04   16  P191 M Daurel-Receveur (1); S Picard (1); K Titier (1); D Ducint (1); F Pehourcq (1); N Moore (1); M Molimard (1); FULLY AUTOMATED ANALYTICAL METHOD FOR MYCOPHENOLIC ACID QUANTIFICATION IN HUMAN PLASMA USING ON-LINE SOLID PHASE EXTRACTION AND HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION
Abstract complet
(1) Laboratoire de pharmacologie clinique et de toxicologie, Université V. Segalen, CHU Pellegrin, BORDEAUX;
Poster Mercredi 16/04   16  P192 M Cucherat (1); E Amsallem (1); JP Boissel (1); TRIALYS : A KNOWLEDGE DATABASE OF CLINICAL TRIALS RESULTS
Abstract complet
(1) EA 643, Faculté de Médecine Laennec, LYON;
Poster Mercredi 16/04   16  P193 S Belgun – florea (1); S Briançon (2); J Doury (1); H Fessi (2); DEVELOPMENT OF A NEW PHARMACEUTICAL FORMULATION EFFECTIVE IN PREVENTION AND/OR TREATMENT OF DENTO-PERIODONTAL DISEASES
Abstract complet
(1) Laboratoire de recherche en santé publique (Lass – UMR 5823 CNRS), Faculté d’odontologie, 11 rue Guillaume Parradin, LYON; (2) Laboratoire d’Automatique et de Génie des Procédés (Lagep-UMR 5007CNRS), Univ. C. Bernard Lyon1, 43 bd du 11 novembre 1918, VILLEURBANNE;
Poster Mercredi 16/04   16  P194 AN Barkun (1); V Adam (2); W Kennedy (3); CA Fallone (1); K Herba (1); M Bardou (1); THE COST-EFFECTIVENESS OF HIGH DOSE ORAL VERSUS INTRAVENOUS PROTON PUMP INHIBITION IN HIGH-RISK PATIENTS WITH BLEEDING PEPTIC ULCERS HAVING UNDERGONE THERAPEUTIC ENDOSCOPY
Abstract complet
(1) Gastroenterology Department, McGill University Health Center, MONTREAL, CANADA; (2) Division of epidemiology, McGill University, MONTREAL, CANADA; (3) Faculté de pharmacie, Université de Montréal, MONTREAL, CANADA;
Poster Mercredi 16/04   16  P195 P Nicolas (1); B Uzzan (1); M Cucherat (2); JP Boissel (2); GY Perret (1); THE ROLE OF MICROVESSEL DENSITY (MVD) ON THE SURVIVAL OF PATIENTS WITH BREAST CARCINOMA : A SYSTEMATIC REVIEW OF THE LITERATURE WITH META-ANALYSIS
Abstract complet
(1) Lab Pharmacologie, Faculté de Médecine – CHU Bobigny, BOBIGNY; (2) Lab Pharmacologie, Faculté de Médecine – Université Lyon 1, LYON;
Poster Mercredi 16/04   17  P196 S Oger (1); C Mehats (2); E Dallot (1); F Ferré (1); D Cabrol (1); MJ Leroy (1); UTERO-RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF SELECTIVE PDE4 (cAMP-SPECIFIC PHOSPHODIESTERASES) INHIBITORS IN HUMAN MYOMETRIUM
Abstract complet
(1) INSERM U361, Maternité Port Royal Cochin, Université Paris 5, PARIS; (2) Division of Reproductive Biology, Stanford University School of Medicine, STANFORD, ETATS-UNIS;
Poster Mercredi 16/04   17  P197 C Rouget (1); MJ Leroy (2); M Breuiller-Fouché (2); C Loustalot (3); E Morcillo (4); T Croci (5); E Naline (1); F Ferré (2); C Advenier (1); M Bardou (1); ABSENCE OF DESENSITISATION OF BETA 3 ADRENERGIC RESPONSE IN HUMAN NEAR-TERM MYOMETRIUM
Abstract complet
(1) UPRES EA220, UFR Biomédicale des Saints Pères, PARIS; (2) INSERM U361, Pavillon Baudelocque, PARIS; (3) CHU du Bocage, Dijon, DIJON; (4) Département de Pharmacologie, Université de Valence, VALENCE, ESPAGNE; (5) Centre de recherche Sanofi-Midy, Milan, MILAN, ITALIE;
Poster Mercredi 16/04   17  P198 N Geffroy (1); A Guédin (1); P Formstecher (1); C Dacquet (2); P Lefebvre (1); CHARACTERIZATION OF NON GENOMIC EFFECTS OF ESTROGENS IN HELA AND MCF7 CELLS
Abstract complet
(1) INSERM U459, Faculté de Médecine H Warembourg, LILLE; (2) Institut de Recherches Servier, IRIS, COURBEVOIE;
Poster Mercredi 16/04   17  P199 M Sarr (1); JC Alencar (1); JC Stoclet (1); VB Schini-Kerth (1); B Muller (2); LONG-LASTING INHIBITION OF ARTERIAL TONE BY NO IN VARIOUS VASCULAR BEDS: DIFFERENTIAL INFLUENCE OF THE ENDOTHELIUM
Abstract complet
(1) UMR 7034, Faculté de Pharmacie, STRASBOURG; (2) INSERM 9937, UFR Sciences Pharmaceutiques & EMI, BORDEAUX;
Poster Mercredi 16/04   17  P200 K Papa (1); N Simon (1); B Bruguerolle (1); EFFECTS OF CHLORPYRIFOS ON OXIDATIVE PHOSPHORYLATION OF ISOLATED RAT MITOCHONDRIA
Abstract complet
(1) Laboratoire de Pharmacologie médicale et clinique, Faculté de médecine, MARSEILLE;
Poster Mercredi 16/04   17  P201 B Guillet (1); L Velly (1); S Lortet (2); F Masmejean (2); A Nieoullon (2); P Pisano (1); REGULATION OF ACTIVITY AND CELL SURFACE EXPRESSION OF GLUTAMATE TRANSPORTERS IN NEURON-ENRICHED CULTURES REQUIRES PHOSPHORYLATION
Abstract complet
(1) Laboratoire de pharmacodynamie, UFR Pharmacie, 27 bd Jean Moulin, MARSEILLE; (2) LNCF, FRE CNRS 2131, 31 Chemin Joseph Aiguier, MARSEILLE;
Poster Mercredi 16/04   17  P202 L Favot (1); T Keravis (1); V Holl (2); C Lugnier (1); INVOLVEMENT OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASES (PDES) IN ANGIOGENESIS
Abstract complet
(1) UMR CNRS 7034, Faculté de pharmacie, ILLKIRCH; (2) Laboratoire de Cancérologie Expérimentale et de Radiobiologie (LCER), IRCAD, STRASBOURG;
Poster Mercredi 16/04   17  P203 A Maguy (1); D Godreau (1); R Vranckx (1); C Goyenvalle (1); S Hatem (1); SAP-97 PROMOTES HKV1.5 COMPARTMENTATION TO LIPID RAFTS AND INTERACTION WITH BETA-SUBUNIT: CONSEQUENCES ON CURRENTS PROPERTIES
Abstract complet
(1) U460 INSERM, Faculté de médecine X. BICHAT, PARIS;
Poster Mercredi 16/04   17  P204 A Maguy (1); S Hatem (1); D Godreau (1); NEW PROCEDURE TO REALISE CELL LINE STABLY EXPRESSING A CLONED PROTEIN
Abstract complet
(1) U460 INSERM, Faculté de médecine X. BICHAT, PARIS;
Poster Mercredi 16/04   17  P205 C Moro (1); J Galitzky (1); C Sengenès (1); F Crampes (1); M Lafontan (1); M Berlan (1); EVALUATION OF ANP-INDUCED LIPOLYSIS ANTAGONISTS IN HUMAN ADIPOSE TISSUE.
Abstract complet
(1) INSERM U317, Faculté de Médecine, TOULOUSE;
Poster Mercredi 16/04   17  P206 C Labrande (1); F Masmejean (2); S Lortet (2); A Nieoullon (2); P Pisano (1); NEUROPROTECTIVE EFFECTS OF TACROLIMUS DURING IN VITRO CEREBRAL ISCHEMIA : INSIGHTS ON THE ROLE OF GLUTAMATE
Abstract complet
(1) Laboratoire pharmacodynamie, Faculté Pharmacie 27 bd Jean Moulin, MARSEILLE; (2) FRE CNRS 2131, 31 Chemin Joseph Aiguier, MARSEILLE;
Poster Mercredi 16/04   18  P207 C Brefel-Courbon (1); P Payoux (2); C Thalamas (3); I Quelven (2); M Galitzky (3); JL Montastruc (1); JP Esquerre (2); F Chollet (4); O Rascol (1); LEVODOPA EFFECT ON EXPERIMENTAL PAIN IN PARKINSON’S DISEASE: A CLINICAL AND NEUROIMAGING PILOT STUDY
Abstract complet
(1) Service de Pharmacologie, INSERM U455, Faculté de Médecine, TOULOUSE; (2) Service de medecine nucléaire INSERM U455, CHU Purpan, TOULOUSE; (3) Centre d’investigation clinique, CHU Purpan, TOULOUSE; (4) INSERM U455, CHU Purpan, TOULOUSE;
Poster Mercredi 16/04   18  P208 J Micallef (1); S Tardieu (1); S Durand (1); G Masson (2); D Mestre (2); O Blin (1); EFFECTS OF A SUBANESTHETIC DOSE OF KETAMINE ON SACCADIC EYE MOVEMENTS IN HEALTHY SUBJECTS
Abstract complet
(1) CPCET & Institut de Neurosciences Physiologiques et Cognitives, CHU Timone, MARSEILLE; (2) Centre de Recherches en Neurosciences Cognitives, CNRS, MARSEILLE;
Poster Mercredi 16/04   18  P209 O Rascol (1); D Brooks (2); W Olanow (3); G Koch (4); PH Truffinet (5); R Bejuit (5); The Riluzole 320 Study Group (6); THE EFFECT OF RILUZOLE ON PARKINSON’S DISEASE PROGRESSION : A 2-YEAR TRIAL
Abstract complet
(1) Service de Pharmacologie, INSERM U455, Faculté de Médecine, TOULOUSE; (2) Hammersmith Hospital, MRC Cyclotron Unit, LONDON, UK; (3) Mount Sinai, Medical Center, NEW YORK, USA; (4) Biostatistics Department, Chapel Hill, CHAPEL HILL, USA; (5) Aventis, ANTONY; (6) 122 Investigators from eleven countries, INTERNATIONAL;
Poster Mercredi 16/04   18  P210 H Allain (1); D Bentue-Ferrer (1); A Tarral (2); O Tribut (1); E Polard (3); JM Gandon (2); EFFECTS ON POSTURAL OSCILLATION AND MEMORY FUNCTIONS OF A SINGLE DOSE OF ZOLPIDEM 5MG, ZOPICLONE 3.75MG AND LORMETAZEPAM 1MG IN ELDERLY HEALTHY SUBJECTS
Abstract complet
(1) Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine, RENNES; (2) BIOTRIAL S.A., Atalante Villejean, RENNES; (3) Centre de Pharmacovigilance, Hôpital Pontchaillou, RENNES;
Poster Mercredi 16/04   18  P211 G Pickering (1); V Batel (1); A Eschalier (1); C Dubray (1); ANALGESICS CONSUMPTION AND ALZHEIMER’S DISEASE
Abstract complet
(1) INSERM EMI 9904 Laboratoire de Pharmacologie Médicale, Faculté de Médecine BP38 CHU, CLERMONT-FERRAND;
Poster Mercredi 16/04   19  P212 C Sévoz-Couche (1); MA Comet (1); M Hamon (1); R Laguzzi (1); INVOLVEMENT OF NUCLEUS TRACTUS SOLITARIUS (NTS) 5-HT3 AND GABAA RECEPTORS IN THE DEFENSE REACTION-INDUCED INHIBITION OF AORTIC BAROREFLEX BRADYCARDIA IN THE RAT
Abstract complet
(1) INSERM U288, Faculté de médecine Pitié-Salpêtrière, PARIS;
Poster Mercredi 16/04   19  P213 A Kreisler (1); P Gelé (2); A Destée (1); R Bordet (2); NEUROPROTECTIVE EFFECT OF PPAR-ALPHA AGONIST IN THE MPTP MOUSE MODEL OF PARKINSON’S DISEASE
Abstract complet
(1) EA 2643, Neurologie A, CHRU, LILLE; (2) EA 1046, Pharmacologie, Faculté de Médecine, LILLE;
Poster Mercredi 16/04   19  P215 V Lelong (1); F Dauphin (2); M Boulouard (1); LOCALIZATION OF 5-HT4 RECEPTORS IMPLICATED IN WORKING MEMORY IN MICE: EFFECT OF SEROTONERGIC LESIONS ON BEHAVIOURAL AND NEUROCHEMICAL (BINDING SITES DENSITY) PARAMETERS
Abstract complet
(1) UPRES EA 2126, Faculté de Pharmacie, Université de Caen, CAEN; (2) UMR 6551, Université de Caen, CAEN;
Poster Mercredi 16/04   19  P216 H Legros (1); F Janin (1); N Dourmap (1); JJ Bonnet (1); J Costentin (1); SEMI-CHRONIC INCREASE IN STRIATAL LEVEL OF 3,4-DIHYDROXYPHENYLACETALDEHYDE DOES NOT RESULT IN ALTERATION OF NIGRO-STRIATAL DOPAMINERGIC NEURONS
Abstract complet
(1) Unité de NeuroPsychoPharmacologie Expérimentale UMR 6036 CNRS, Faculté de Médecine et de Pharmacie, ROUEN;
Poster Mercredi 16/04   19  P217 P Bredeloux (1); A Tabarly (1); I Dubuc (1); J Martinez (2); J Costentin (1); MICE MADE TOLERANT TO MORPHINE ANALGESIA ARE ALSO TOLERANT TO THE ANALGESIC EFFECT OF A CYCLIC ANALOG OF NEUROTENSIN
Abstract complet
(1) UMR 6036 CNRS, Unité de neuropsychopharmacologie expérimentale, IFRMP23, Faculté de Médecine et de Pharmacie, ROUEN; (2) Laboratoire des Aminoacides, peptides et protéines ESA 5075, Faculté de pharmacie, MONTPELLIER;
Poster Mercredi 16/04   19  P218 MA Comet (1); C Sévoz-Couche (1); M Hamon (1); R Laguzzi (1); ACTIVATION OF THE PERIAQUEDUCTAL GRAY MATTER INHIBITS THE CARDIAC COMPONENT OF THE BARORECEPTOR REFLEX VIA STIMULATION OF 5-HT3 RECEPTORS IN THE RAT NUCLEUS TRACTUS SOLITARIUS
Abstract complet
(1) INSERM U288, Faculté de médecine Pitié-Salpêtrière, PARIS;
Poster Mercredi 16/04   19  P219 JP Guilloux (1); C Przybylski (1); F Artigas (2); M Toth (3); AM Gardier (1); EFFECT OF COADMINISTRATION OF PAROXETINE AND (±)-PINDOLOL ON EXTRACELLULAR SEROTONIN : A NOVEL APPROACH USING KO 5-HT1A MICE
Abstract complet
(1) EA 3544 Lab. Neuropharmacologie, Faculté de Pharmacie Université Paris-Sud, CHATENAY-MALABRY; (2) Departement of Neurochemistry, Institut d’Investigacions Biomediques, BARCELONA, SPAIN; (3) Department of pharmacology, Weill Medical College of Cornell University, NEW YORK, USA;
Poster Mercredi 16/04   19  P220 J Couturier (1); N Croci (1); M Plotkine (1); I Margaill (1); 3-AMINOBENZAMIDE, A POLY(ADP-RIBOSE) POLYMERASE INHIBITOR, REDUCES BRAIN INFARCTION AND POLYMORPHONUCLEAR NEUTROPHIL INFILTRATION AFTER CEREBRAL ISCHEMIA/REPERFUSION IN MICE
Abstract complet
(1) Laboratoire de Pharmacologie UPRES EA2510, Université René Descartes Paris V, PARIS;

Page précédente